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Abstract 
Ligand-activated nuclear receptors (NRs) are transcription factors that link the regulation of gene 
expression directly to the body’s hormonal and nutritional status. The vitamin D receptor (VDR) is a NR 
activated by the hormone 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3). In the organism, 1α,25(OH)2D3 
synthesis mostly results from the initial stimulus from the UV portion of sunlight. This solar-powered 
transcription factor primarily regulates mineral homeostasis but is also an important modulator of the 
immune-system and cellular proliferation, thereby counteracting tumorigenesis. 
Regulation of the cell cycle by the cyclin-dependent kinase-inhibitor p21CIP1/WAF1 (encoded by the human 
gene CDKN1A, hereafter called p21) has been suggested as one of the anti-proliferative mechanisms of 
1α,25(OH)2D3. Our results further establish p21 gene as a primary target of 1α,25(OH)2D3 by 
characterizing three novel 1α,25(OH)2D3-responsive regions residing up to 7 kbp upstream of the p21 
transcription start site (TSS). These regions are ligand-dependently enriched with VDR, as assayed by 
chromatin-immunoprecipitation. Interestingly, the tumor suppressor p53 also binds two of these regions. 
Comparison of co-activator association of VDR and another NR, the peroxisome proliferator-activated 
receptor β/δ (PPARβ/δ) on the regulatory regions of the p21 gene and on those of the pyruvate 
dehydrogenase kinase (PDK) gene family, respectively, supports the stricter ligand-dependency of the 
VDR. The modulation of 1α,25(OH)2D3 response by co-repressors and associated histone deacetylases 
(HDACs) showed that combined treatment of 1α,25(OH)2D3 and the HDAC inhibitor trichostatin A 
(TSA) achieved maximal induction of the p21 gene and the other cyclin-dependent kinase inhibitor 
(CDKI) genes studied. Assays using small-inhibitory RNA (siRNA) knockdown revealed that HDAC3 
and HDAC7 restricted the response to 1α,25(OH)2D3 whereas nuclear co-repressor 1 (NCoR1) and un-
liganded VDR attenuated the response to TSA. 
We also provide evidence that the p21 gene derived steady state mRNA expression responds to 
1α,25(OH)2D3 in a cyclical manner. This results from sequential and cyclical association of VDR, RNA 
polymerase II (Pol II) and co-factors on the regulatory regions of the p21 gene with simultaneous 
chromatin looping that connects the 1α,25(OH)2D3-responsive regions to the TSS. Inhibition of either 
HDAC4, the histone-specific lysine demethylase LSD1 or the MED1 subunit of the Mediator complex 
disturbs both the ligand-induced changes in histone patterns and the chromatin looping, which lead to the 
attenuation and distortment of the cyclical accumulation of mRNA transcripts. These results suggest 
strong interplay between histone modifications, chromatin looping and transcriptional response in gene 
regulation by NRs. 
Concisely, this thesis further establishes the human p21 gene as a primary 1α,25(OH)2D3 target and 
provides insight into the mechanism of NR-dependent activation of transcription with special emphasis on 
chromatin modifying enzymes and chromatin looping. 
Universal Decimal Classification: 575.113, 577.214, 577.218 
National Library of Medicine Classification: QU 56, QU 141, QU 173, QU 470, QU 475 
Medical Subject Headings: Genes; Gene Expression Regulation; Transcription Factors; Chromatin; 
Receptors, Cytoplasmic and Nuclear; Response Elements; Calcitriol; Receptors, Calcitriol; Histones; 
Histone Deacetylases; Gene Silencing; Cyclin-Dependent Kinase Inhibitor p21; 
Cell Cycle; Peroxisome Proliferator-Activated Receptors 
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1. Introduction 
Genes carry the inheritable information in the form of DNA (or in the case of certain viruses, in 
the form of RNA), which is first transcribed to a messenger molecule, mRNA. RNA in turn is 
translated into an effector molecule, a protein. This Central Dogma, with its distinctive polarity, 
presented by Francis Crick in 1958 suggests that the genome of an organism forms its biological 
blueprint (Crick, 1958). The process of reading the blueprint, however, is far from simple. First 
of all, one gene can code for multiple distinct RNA molecules via alternative exon splicing, a 
phenomenon that occurred in 30 % of expressed sequences in a human embryonic kidney cell 
line (Sultan et al., 2008). Secondly, a substantial portion of RNA molecules does not code for 
proteins but participates in regulation of transcription, splicing, degradation or translation of 
mRNA (Amaral et al., 2008). Additionally, less than 2% of the human genome sequence consists 
of protein-coding genes, leaving the large majority of the genome for multiple regulatory 
functions. Finally, the human genome codes for roughly the same number of genes than that of 
the nematode Caenorhabditis elegans, therefore stating that the number of protein coding genes 
does not correlate with an organism’s corporeal complexity (Clamp et al., 2007 These facts 
emphasize the importance of the non-protein coding part of the genome, stressing the role of 
regulation of gene expression. 
The process of gene expression is tightly controlled at multiple levels with increasing complexity 
in higher organisms. In eukaryotes, the packaging of DNA into chromatin forms the first barrier 
against aberrant transcription. Chromatin structure is formed of nucleosomes, where 146 bp of 
DNA is wrapped almost twice around the protein octamer that consists of core histones H2A, 
H2B, H3 and H4. An additional 20 to 90 bp linker region of DNA that straddles from one 
nucleosome core to another is associated with histone H1.  Disrupting the nucleosomes over the 
core promoter of a yeast gene is sufficient to activate transcription in the absence of activating 
signals (Zhang and Reese, 2007). In addition to the barrier function, the purpose of the packaging 
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is to achieve maximal compactivity while maintaining DNA adequately accessible to regulatory 
proteins and transcription (Wu et al., 2007).  
The mRNA synthesis is carried out by Pol II in eukaryotes, which also transcribes a large number 
of non-protein coding RNAs. The first step in the activation of transcription is the recognition of 
specific DNA sequences by transcription factors that trigger the recruitment of co-activators, 
basal transcription machinery, and Pol II to form a preinitiation complex (PIC). This process is 
dependent on the presence of the Mediator complex, through which sequence-specific 
transcription factors are able to contact the basal transcription factors and Pol II. The assembly of 
the PIC begins with binding of TFIID complex to core promoter recognition sequence, such as 
the TATA-box. Histone modifications on the core promoter strongly affect TFIID binding 
(Vermeulen et al., 2007). Subsequently TFIIA, TFIIB and the non-phosphorylated Pol II-TFIIF 
complex join the TFIID. Finally, TFIIE recruits TFIIH, which phosphorylates the serine at 
position 5 in the carboxy-terminal domain of the largest subunit of Pol II (serine 5 phophorylated 
Pol II). The TFIIE-TFIIH complex melts the DNA double strand on the promoter to enable the 
synthesis of RNA on the DNA template (Lin and Gralla, 2005). Interestingly, the Mediator 
complex promotes both the recruitment and the catalytic activity of TFIIH, leading to increased 
serine 5 phophorylated Pol II. This form of Pol II is not able to bind the Mediator complex and 
eventually phosphorylation leads to dissociation of the Mediator from the complex (Esnault et al., 
2008). The serine 5 phosphorylated Pol II also recruits the enzymes that cap the nascent transcript 
at its 5' end. Pol II then pauses until the Positive Transcription Elongation Factor b (P-TEFb) 
elongation complex phosphorylates serine 2 of the largest Pol II subunit, which is required for 
both productive elongation as well as the recruitment of mRNA splicing and polyadenylation 
complexes (Peterlin and Price, 2006). This multi-faceted process offers a vast amount of potential 
regulatory targets, from chromatin context and its interplay with the sequence-specific and basal 
transcription factors right through to the splicing, modification and transport of mRNA.  
Control of the translational efficacy and post-translational modifications that modulate the 
activity and stability of proteins, together with their discrete cellular compartmentalization, 
constitute the last steps in the regulation of gene expression. 
Introduction 
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In summary, the immense complexity of this process enables the multiplicity of adaptable 
expression patterns that ultimately leads to distinct cell and tissue type states. 
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2. Review of the literature 
2.1 Regulation of gene expression by nuclear receptors 
The NR family of transcription factors controls all aspects of animal physiology: homeostasis, 
differentiation, development, sexual maturation and the response to stress. The activity of most 
NRs is regulated by small hydrophobic ligands, such as sex steroids, nutrition-derived fatty acids, 
xenobiotic lipids or fat-soluble vitamins A and D, whereas other NRs appear not to have ligands. 
NRs generally contain two highly conserved zinc finger motifs that recognize specific sequences 
on the genome, called response elements (REs). Regulation of gene expression by NRs provides 
multi-cellular animals with the ability to modify the metabolism, development and growth of 
tissues based on developmental or environmental stimuli in a synchronized manner. 
2.1.1 Classification of NRs 
NRs form a superfamily of transcription factors with 48 members in the human genome 
(Robinson-Rechavi et al., 2001). They can be classified based on ligand sensitivity (Chawla et 
al., 2001), evolution of NR genes (Bertrand et al., 2004) or their physiological role as interpreted 
from tissue-specific expression patterns (Bookout et al., 2006). The ligand sensitivity approach 
suggests three classes: endocrine receptors with high-affinity hormonal lipids, such as the 
estrogen receptors α and β (ERα, β), the androgen receptor (AR) and VDR; adopted orphan 
receptors that binds to dietary lipids and xenobiotics with low affinity. This group includes the 
PPARs α, β/δ and γ. As a final class, by this ligand driven definition, the orphan receptors, for 
which a physiological ligand has not yet been identified, is represented by such examples as 
estrogen-related receptor α (ERRα). 
When the sequences of NRs are compared, the grouping significantly differs from the ligand-
centered view, e.g., VDR belongs to the same group with PPARs (group NR1), and highly 
ligand-sensitive ERs and orphan ERRs are both in group NR3. On the basis of transcriptomes 
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derived from multiple mouse tissues, NRs can be divided into clades with distinct physiological 
roles (Bookout et al., 2006). In this classification, PPARs are linked to lipid metabolism and 
energy homeostasis, whereas VDR is grouped with bile acid and xenobiotic metabolism based on 
its high expression in gastroentric tissues. 
2.1.2 VDR and 1α ,25(OH)2D3 
2.1.2.1 1α ,25(OH)2D3 metabolism 
Vitamin D3 (cholecalciferol) is formed in response to sunlight in skin, where ultraviolet (UV) B 
radiation converts 7-dehydrocholesterol to pre-vitamin D3, which is isomerized to vitamin D3 in a 
heat-dependent process in epidermal basal layers (Holick, 2003b). Vitamin D can also be 
acquired from the diet, either as D2 from plants or D3 derivatives obtained from animals. These 
sources can either be part of the traditional diet or be in the form of supplements. However at 
high latitudes (such as Finland) the basal requirement is not met despite vitamin D, 
 fortification of dairy products (Lehtonen-Veromaa et al., 2008) and this leads to sub-optimal 
levels of the hormone in the general human population. Vitamin D3 is, itself, biologically inactive 
and two hydroxylation steps are needed for the synthesis of the physiologically active form, 
1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3). Vitamin D3 is first hydroxylated by the 25-
hydroxylase (encoded by the gene CYP27A1) in liver, and the resulting 25-hydroxyvitamin D3 
(25(OH)D3), the major circulating form of vitamin D3, is subsequently hydroxylated to the active 
form by the 1α-hydroxylase enzyme (encoded by the gene CYP27B1) in the kidney. However, 
the latter enzyme is also expressed in colon, brain, skin and breast tissues, and this may provide 
tissue-specific control of 1α,25(OH)2D3 levels (Deeb et al., 2007). The physiologically active 
form is inactivated by the 24-hydroxylase (encoded by the gene CYP24A1), which can also 
hydroxylate 25(OH)D3 and is the rate-limiting enzyme in 1α,25(OH)2D3 catabolism. This 
metabolism is regulated by 1α,25(OH)2D3, which strongly induces the expression of the 
CYP24A1 gene and decreases the expression of CYP27B1 (Anderson et al., 2003). Moreover, 
linked to the physiological role of 1α,25(OH)2D3, high Ca2+ and Pi concentration inhibit the 
synthesis of the nuclear hormone, whereas parathyroid hormone (PTH) induces it via increasing 
CYP27B1 gene expression (Bland et al., 1999). 
Review of the literature 
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2.1.2.2 Structure and function of the VDR  
The VDR protein is composed of domains that allow it to translocate to the nucleus, bind its 
ligand, heterodimerize with the retinoid X receptor (RXR), bind to DNA, and finally, to interact 
with co-factors (Carlberg, 2003). In the absence of ligand, VDR is partitioned between the 
cytoplasm and nucleus, whereas ligand induces interaction of VDR with importin β via its 
nuclear localization signal regions. This increases nuclear translocation of VDR, as well as the 
translocation of the VDR-RXR complexes (Yasmin et al., 2005). The ligand-binding domain 
(LBD) in the C-terminal of the protein binds 1α,25(OH)2D3 at sub-nanomolar concentrations and 
also contains the transactivation domain that includes helix 12, which is also called AF-2 
(Carlberg, 2003). This transactivation domain is essential for the ability of NR to activate target 
gene transcription, as the change of positioning of helix 12 upon ligand binding creates a binding 
surface that favors the interaction with co-activators (CoAs) instead of co-repressors (CoRs) 
(Nagy and Schwabe, 2004). 
The dimerization domains in the LBD and the DNA-binding domain (DBD) allow association of 
the VDR with RXR. This interaction is induced by 1α,25(OH)2D3 (Cheskis and Freedman, 1996). 
The VDR-RXR heterodimer binds to specific DNA target sequences in DNA, termed vitamin D 
response elements (VDREs), that consist of two half-sites with the sequence RGKTCA (R = A or 
G, K = G or T) separated by three to four spacing nucleotides (Wang et al., 2005). The DBD on 
the N-terminal of VDR binds to the 3’ half-site of VDREs, while the corresponding DBD of RXR 
binds the 5’ half-site (Kurokawa et al., 1993). VDR-RXR heterodimers prefer direct repeats (DR) 
with 3 spacing nucleotides (DR3), although they also bind to DR4-type VDRE, and to everted 
repeats (ER) with 6, 7, 8 or 9 spacing nucleotides (ER6, ER7, ER8 and ER9) (Schräder et al., 
1995, Wang et al., 2005, Tavera-Mendoza et al., 2006). VDR homodimers have also been 
characterized both in vitro and in vivo (Carlberg 1993), but their physiological relevance remains 
to be under debate as the heterodimer complexes are considerably more stable (Jurutka et al., 
2002; Kahlen and Carlberg, 1994). The heterodimer is able to bind DNA also in non-liganded 
form, but ligand enhances this interaction (Ross et al., 1993).  
Certain responses to 1α,25(OH)2D3 are very rapid (seconds to minutes) and take place in the 
presence of transcription inhibitors. Examples of this type of behavior are the opening of voltage-
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gated Ca2+ and Cl– channels, the activation of phospholipase A and C as well as the induction of 
several signaling cascades, including protein kinase C and mitogen-activated protein kinase 
(MAPK) pathways (Norman, 2006). These non-genomic actions are suggested to be exerted by 
VDR associated with caveolae present in the plasma membrane and they may interact with the 
genomic actions, for instance, by the modulation of the transcriptional response to liganded VDR 
by its phosphorylation. 
2.1.2.3 Target genes and physiological role of 1α ,25(OH)2D3 
The effect of 1α,25(OH)2D3 on the transcriptome (the total mRNA expressed in a cell or tissue at 
a given point in time) has been assayed by multiple microarray experiments, with, for example, 
over 900 genes responding after 12 h of ligand treatment in the presence of the protein synthesis 
inhibitor cycloheximide in the human head and neck squamous cell carcinoma line SCC25 
(Wang et al., 2005). As the transcriptional response is highly dependent on cells or tissue used, 
duration of the treatment, concentration of the ligand and co-treatments, there are an infinite 
number of putative responding transcriptomes, resulting in various physiological outcomes. This 
section describes selected physiological effects of 1α,25(OH)2D3 along with examples of target 
genes that are suggested to be responsible for the effects. 
Ca2+ and Pi homeostasis and bone mineralization 
The most striking effect of severe vitamin D deficiency is rickets. Rickets can also by inflicted by 
mutations in the gene of the 1α,25(OH)2D3 synthesizing enzyme 1αOH-ase, CYP27B1, or in the 
VDR gene itself. 1α,25(OH)2D3 is essential for adequate Ca2+ and Pi absorption from the intestine 
and hence for bone formation (Renkema et al., 2008). Liganded VDR has been shown to induce 
expression of the gene encoding for the major Ca2+ channel in intestinal epithelial cell, transient 
receptor potential vanilloid type 6 (TRPV6), by direct binding on a functional VDRE at -1.2 kbp 
from the TSS (Meyer et al., 2006). A phosphate transporter is also induced, but the response on 
chromatin level is less characterized (Xu et al., 2002). 1α,25(OH)2D3 also down-regulates the 
expression of the PTH gene that opposes 1α,25(OH)2D3 in regulation of serum Ca2+ and Pi levels, 
but up-regulates FGF23, which, like PTH, lowers serum Pi levels (Liu et al., 1996a, Saito et al., 
2005). The induction of the RANKL gene by liganded VDR via multiple distant VDREs (up to 70 
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kbp from the TSS) leads to stimulation of osteoclast precursors to fuse and form new osteoclasts, 
resulting in enhanced resorption of the bone (Kim et al., 2007). 
Feedback loop regulation of 1α,25(OH)2D3 metabolism 
Liganded VDR down-regulates the last step of ligand synthesis by inhibiting CYP27B1 
expression in the kidney. This is suggested to occur via a negative RE or a mixture of positive 
end negative elements (Murayama et al., 2004; Turunen et al., 2007). In the absence of 
1α,25(OH)2D3, the negative element binds the transcriptional activator transcription factor 3 
(TCF3, also called VDIR) associated with CoAs, whereas the liganded VDR-RXR complex binds 
to TCF3 and attracts CoRs (Murayama et al., 2004). Association of VDR-RXR heterodimers to 
TCF3 binding sites may also occur through ligand-dependent chromatin looping from more distal 
regions that directly bind the VDR (Turunen et al., 2007). 1α,25(OH)2D3 highly induces 
expression of the CYP24A1 gene through multiple binding sites, thus increasing the inactivating 
hydroxylation step and its own catabolism (Väisanen et al., 2005). Liganded VDR also induces 
its own expression (Brown et al., 1995). 
Modulation of the immune system 
Already in the early 20th century sunlight exposure was used as a treatment for tuberculosis and in 
recent years some of the molecular mechanisms involved in the immuno-modulatory actions of 
1α,25(OH)2D3 have been revealed. 1α,25(OH)2D3 enhances the innate immune response, such as 
in the case of tuberculosis, and modulates the adaptive immunity towards self-tolerance and 
inhibition of autoimmune diseases (Adorini and Penna, 2008). The anti-autoimmune effect of 
1α,25(OH)2D3 is evidenced by epidemiological studies where the vitamin D system reduces the 
risk of type I diabetes, multiple sclerosis, inflammatory bowel disease, rheumatoid arthritis and 
systemic lupus erythematosus (Adorini and Penna, 2008). At the cellular level, 1α,25(OH)2D3 has 
been shown to induce myeloid differentiation and phagocytosis by macrophages as well as inhibit 
the development and responses of proinflammatory TH1 cells, proinflammatory responses of 
pathogenic TH17 cells, proliferation, plasma-cell differentiation and immunoglobulin production 
of B-cells and to modulate antigen presenting dendritic cells to act tolerogenically, to induce the 
differentiation and expression of regulatory T cells (Baeke et al., 2008; Adorini and Penna, 2008; 
Mora et al., 2008). Regulatory T cells suppress the effector functions of other immune cells and 
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are crucial in maintenance of peripheral self-tolerance (Mora et al., 2008). There are also adverse 
immuno-suppressive effects of 1α,25(OH)2D3 signaling, as suggested by increased resistance of 
VDR knockout mice to the intracellular protozoan Leishmania major when compared to wild-
type littermates (Ehrchen et al., 2007). 
At the molecular level, the curing power of sunlight is explained by a 1α,25(OH)2D3-dependent 
process in the innate immunity system: Toll-like receptors in macrophages recognize 
Mycobacterium tuberculosis-derived ligands and induce expression of VDR and CYP27B1 genes, 
leading to increased liganded VDR that in turn augments the expression of the anti-microbial 
peptide cathelicidin (Gombart et al., 2005; Liu et al., 2006). Induction of cathelicidin by 
1α,25(OH)2D3 occurs also in keratinocytes in response to injury, where TGF-β induces CYP27B1 
expression, leading to increased 1α,25(OH)2D3 concentration that then triggers expression of the 
genes coding for pattern recognition receptors Toll-like receptor 2 and CD14 in addition to that 
coding for cathelicidin (Schauber et al., 2007). 
1α,25(OH)2D3 inhibits maturation and cytokine production of dendritic cells by repressing the 
expression of the v-rel reticuloendotheliosis viral oncogene homolog B (RELB) gene, that codes 
for a subunit of NF-κB, via binding of VDR-RXR heterodimer on two VDREs upstream of TSS, 
the mouse equivalent of which ligand-dependently recruits HDAC3 to the heterodimer (Dong et 
al., 2003; Dong et al., 2005). In T cells 1α,25(OH)2D3 inhibits the expression of TH1 –type 
cytokines interferon-γ and interleukin-2 (IL-2) as well as the expression of IL12B that codes for 
the p40 subunit of IL-23, which induces IL-17 production linked to inflammation and 
autoimmune diseases (Adorini and Penna, 2008). A new candidate for the ability of 
1α,25(OH)2D3 to induce myeloid cell differentiation is an inhibitor of the proliferative ERK 
pathway, the human kinase suppressor of Ras 2 (hKSR-2), which contains VDREs with VDR-
RXR heterodimer association and is up-regulated by ligand treatment (Wang et al., 2007).  
Regulation of cell proliferation and tumorigenesis 
The role of 1α,25(OH)2D3 as an anti-proliferative and anti-cancer agent is supported by research 
at multiple levels from epidemiological studies to cell culture models depicting molecular 
mechanisms. Epidemiological studies show a positive correlation between low serum 25(OH)D3 
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levels and increased risk for colorectal, breast and prostate cancers (Deeb et al., 2007). 
Additionally, VDR knockout mice show hyper-proliferation in the colon, accelerated growth and 
induced branching in the mammary gland and are more prone to develop carcinogen-induced skin 
tumors and in situ hyperplasia of the mammary gland (Kallay et al., 2001; Zinser et al., 2002a; 
Zinser et al., 2002b; Zinser et al., 2005). At the cellular level, 1α,25(OH)2D3 induces 
differentiation, apoptosis and cell cycle arrest at G0/G1, and inhibits metastatic and angiogenic 
pathways. The effects of 1α,25(OH)2D3 to cell growth are mild when compared to the 
chemotherapeutic agents currently in use and 1α,25(OH)2D3 itself causes hypercalcemia when 
used in high, anti-cancer quantities. Therefore, neither 1α,25(OH)2D3 nor its non-calcemic 
analogs are currently used as a standard treatment for cancer (Bouillon et al., 2006). As a discreet 
and safe modifier of proliferation, 1α,25(OH)2D3 (originating either from sunlight exposure or 
from food supplements) may be used to prevent cancer. Alternatively, its non-calcemic analogs 
may be used in combination with established chemotherapeutic drugs, a strategy used in many 
ongoing clinical trials, e.g. by Novacea and Hybrigenics (Bouillon et al., 2006; Deeb et al., 
2007). 
The pro-apoptotic effect of 1α,25(OH)2D3 is highly variant among cell and tissue types, as 
1α,25(OH)2D3 also showed anti-apoptotic potential in some studies (Marcinkowska et al., 2001). 
Among apoptosis-related targets, the anti-apoptotic protein BCL-2 is downregulated and the pro-
apoptotic proteins BAX and BAK are upregulated by the ligand (Diaz et al., 2000; Wagner et al., 
2003). Whether the genes encoding these targets respond primarily to 1α,25(OH)2D3 remains to 
be elucidated, since no VDREs have yet been identified in their regulatory regions. Also a 
mechanism involving destabilization of telomerase reverse transcriptase (TERT) gene mRNA by 
1α,25(OH)2D3 has been suggested (Jiang et al., 2004). In addition, a role for caspases, 
intracellular Ca2+ and μ-calpain as well as cathepsins in 1α,25(OH)2D3-mediated apoptosis has 
been proposed, but putative direct genomic targets still remain to be characterized (Byrne and 
Welsh, 2007). 
1α,25(OH)2D3 is also able to hinder the first steps of metastasis by modulation of cellular 
adhesion and epithelial to mesenchymal transition. A hallmark of transition from adenoma to 
carcinoma is the down-regulation of the adhesion molecule E-cadherin, accompanied with the 
loss of the adhesive and polarized phenotype and the release of cells from parent epithelial tissue 
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(Jamora and Fuchs, 2002). E-cadherin binds β-catenin at adherent junctions, thereby inhibiting its 
ability to bind the T-cell factor/lymphoid enhancer factor (TCF/LEF) family of transcription 
factors that activate genes involved in proliferation, invasiveness and angiogenesis. Liganded 
VDR-RXR complexes inhibit this transition both by competing with TCF/LEF transcription 
factors for β-catenin binding and by inducing expression of E-cadherin gene (also known as 
CDH1). However, in tumors these actions are counteracted by the transcriptional repressor 
SNAIL that down-regulates the expression of the VDR gene (Pálmer et al., 2001; Pálmer et al., 
2004). 
Anti-angiogenic effects of 1α,25(OH)2D3 have been shown in cell culture and in nude mouse 
tumor transplant models (Mantell et al., 2000). One suggested explanation for this phenomenon is 
the down-regulation of the hypoxia-induced factor-1 (HIF-1) via reduced protein translation, as 
neither mRNA expression (only measured at one time point) nor the degradation of HIF-1 α 
protein was affected by ligand treatment (Ben-Shoshan et al., 2007). 1α,25(OH)2D3 treatment 
was also shown to reduce the expression of HIF-1 target genes, such as vascular endothelial 
growth factor (VEGF), in a HIF-1-dependent manner. 
The most ubiquitous and well-characterized anti-cancer effect of 1α,25(OH)2D3 is the cell-cycle 
arrest at G0/G1. The factors behind this effect are discussed in the last section of this literature 
review after the general review of cell cycle regulation. 
Anti-cancer activities of 1α,25(OH)2D3 are counteracted by various mechanisms in tumors. In 
addition to the mentioned down-regulation of VDR by increased SNAIL expression in tumors, 
disturbances in expression of genes coding the metabolic enzymes CYP24A1 and CYP27B1 are 
common (Bouillon et al., 2006). Moreover, the ubiquitously overexpressed oncogenic H-ras 
(encoded by HRAS) decreases the stability of VDR mRNA (Rozenchan et al., 2004). Besides 
VDR expression and ligand availability, the transcriptional activation potential of liganded VDR-
RXR complex is compromised in cancer by post-translational modifications of the receptors and 
aberrant expression of co-factors. For example, phosphorylation of RXR at serine 260 by the 
MAPK pathway inhibits co-activator recruitment by liganded VDR-RXR complex, and hence the 
transcriptional activation potential of 1α,25(OH)2D3 (Macoritto et al., 2006). The responsiveness 
to 1α,25(OH)2D3 is also affected by ratio of VDR expression to that of the NR-associated co-
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repressors NCoR1 and/or the Silencing Mediator of Retinoid and Thyroid Receptors (SMRT or 
NCoR2) (Abedin et al., 2006). Ectopic overexpression of NCoR1 abolished the anti-proliferative 
response of a non-malignant mammary cell line (MCF-12A) to 1α,25(OH)2D3 (Abedin et al., 
2006). Additionally, chemical inhibition of chromatin modifiers that associate with co-repressors, 
such as HDACs and DNA methyltransferases, increased or even restored the anti-proliferative 
effect of 1α,25(OH)2D3 or its analogue, 1α,25-dihydroxy-16,23Z-diene-26,27-hexafluoro-19-nor 
vitamin D3 in malignant cell mammary cell lines on the level of proliferation, cell cycle phase 
distribution and target gene expression (Banwell et al., 2006). These findings indicate that co-
repressors and associated chromatin modifiers play a significant role in determination of 
1α,25(OH)2D3 response, and that modification of their activity provides means to augment the 
anti-proliferative effects of 1α,25(OH)2D3. 
2.1.3 PPARβ/δ   
PPARβ/δ forms the PPAR subfamily of NRs with its siblings PPARα and PPARγ. Their 
endogenous ligands are native and oxidized poly-unsaturated fatty acids and arachidonic acid 
derivatives, such as prostaglandins and prostacyclins, which selectively bind the PPAR subtypes 
and stimulate their transcriptional activity (Desvergne et al., 2004). 
Like VDR, PPARs also heterodimerize with RXRs, but they bind to the 5’ half site and prefer 
DR1-type REs (Bardot et al., 1995; IJpenberg et al., 1997). The structure of PPARs resembles 
that of other NRs, such as VDR, but they have a larger ligand-binding cavity as well as 
differences in the AF-2 domain function, that result in high basal activity of PPARs with the 
ability to associate with CoAs even in the absence of ligand (Molnar et al., 2005; Zoete et al., 
2007). The concept of high basal activity of PPARs is still under debate though, because a natural 
ligand was found from the LBD in a re-analysis of the “non-liganded” PPARβ/δ crystal structure, 
raising the question whether naturally occurring ligands could play a significant role in the 
constitutive activity of PPARs (Fyffe et al., 2006). 
PPARβ/δ shows the widest expression pattern among the sub-family and is highly expressed in 
various tissues, indicating a broad role in physiology (Bookout et al., 2006). Because PPARs 
bind ubiquitous nutrition-derived ligands, they regulate various metabolic processes as sensors 
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for the nutritional status. PPARβ/δ controls many aspects of glucose homeostasis and fatty acid 
synthesis/storage, mobilization and catabolism. It increases lipogenesis and reduces glucose 
output in liver, but also increases fatty acid oxidation in adipocytes and oxidative metabolism in 
muscle. In addition, PPARβ/δ increases energy expenditure both in adipocytes and in muscle, and 
controls the fiber type switch in muscle, promoting endurance (Reilly and Lee, 2008). The latter 
effect was seen in ‘marathon mice’ that express a constitutively active PPARβ/δ–VP16 hybrid 
transcription factor in skeletal muscles, which results in an increased exercise endurance with 
muscle type switching as well as in increased resistance to obesity (Wang et al., 2004). 
Convergence of PPAR and VDR pathways has been reported e.g. in adipogenesis, where VDR 
inhibits PPARγ-mediated gene expression. Putative mechanisms for this attenuation are the 
decreased expression of CCAAT enhancer binding protein-alpha (C/EBPα) and PPARγ, reduced 
synthesis of natural PPAR ligands, and/or competition over the common heterodimerization 
partner RXR by VDR (Wood, 2008). Contrary to the PPARγ gene, expression of the PPARβ/δ 
gene is induced by 1α,25(OH)2D3 via a functional VDRE 366 bp upstream of the PPARβ/δ TSS 
(Dunlop et al., 2005). 
2.1.4 NR co-factors 
As the genomic DNA of eukaryotes is packaged into chromatin, NR co-factors are needed to 
alleviate this packaging. Moreover, they interpret and leave messages to the chromatin structure, 
as well as bridge the NRs to the basal transcriptional machinery. Co-regulators also modify 
components of the transactivation complex as well as NRs themselves, control splicing of 
transcripts and regulate the assembly, recruitment and release of co-regulatory complexes 
(Lonard and O'Malley, 2005; Perissi and Rosenfeld, 2005). CoAs that directly bind NRs share a 
common structural motif that interacts with the AF-2 motif of NRs, the nuclear-receptor box with 
a LXXLL composition, where L equals leucine and X equals any amino acid (Heery et al., 1997). 
The interactions of CoAs and CoRs with NRs can be controlled at several levels, including 
expression and post-translational modifications of co-factors and NRs, ligand binding by the NRs 
and histone or DNA modifications in the targeted chromatin, providing integration of multiple 
signaling pathways to the NR transcriptional response (Rosenfeld et al., 2006). Examples of co-
regulators are categorized in the following sections to CoAs and CoRs, although the strict 
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division is artificial and possibly misleading, as multiple factors are essential in both 
transcriptional repression and activation. For example, the well-established CoA p300 acts as a 
repressor for the v-myc myelocytomatosis viral oncogene homolog (avian) gene (MYC gene), 
which encodes for myc proto-oncogene protein (myc), expression in co-operation with HDAC3 
(Sankar et al., 2008).  
2.1.4.1 Co-activators  
The multi-subunit Mediator complex acts as a bridge between NRs and the Pol II machinery and 
thus enables the activation of transcription by NRs and other transcription factors. Although the 
importance of the Mediator complex is well established, its exact mode of function remains 
undefined. The complex is believed to act predominantly during the assembly of the PIC as it is 
recruited to target chromatin prior to Pol II. Putative mechanisms include induction of the PIC 
assembly, recruitment of Pol II or members of the basal transcription machinery and docking of 
other CoAs, such as histone acetyltransferases (HATs) (Casamassimi and Napoli, 2007). The 
MED1 subunit of the Mediator complex is essential for transcriptional activation by many NRs, 
such as VDR, and it interacts with the AF-2 activation domain of NRs through its LXXLL motif 
and thus recruits the entire Mediator complex to the VDR (Casamassimi and Napoli, 2007; 
Rachez et al., 1998). Phosphorylation of MED1 is stimulated by NR ligands and promotes its 
association with the Mediator complex. Phosphorylation of MED1 also enhances NR-dependent 
transcription in vitro, providing additional mechanisms for integration of NR and cell membrane 
receptor pathways (Belakavadi et al., 2008). 
HATs, such as the family of NR CoAs (NCOA1, NCOA2 and NCOA3, also known as SRC-1, -2 
and -3), E1A binding protein p300 (EP300 or p300) and CREB-binding protein (CBP or 
CREBBP), catalyze acetyl group transfer from acetyl-coenzyme A to histones forming coenzyme 
A and acetyl-histones. HATs can also acetylate non-histone targets, such as transcription factors, 
and modify their activity and/or stability. NCOA proteins possess only weak intrinsic HAT 
activity and their main function is the recruitment of histone modifying CoAs to ligand-activated 
and DNA-bound NRs, since, e.g. CBP only weakly binds NRs. The modifiers include CoAs with 
HAT activity, such as p300, CBP and p/CAF, as well as those with histone methyltransferase 
(HMT) activity, such as CARM1 and PRMT1 (Chen et al., 1997; Chen et al., 1999; Sheppard et 
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al., 2001). The actions of HATs and HMTs lead to more permissive chromatin and, more 
importantly, provide docking sites for acetyl-lysine binding bromodomain proteins and methyl-
lysine binding chromodomain proteins with other properties such as chromatin remodeling 
activity. 
The PPARγ co-activator 1 α (PGC-1α) functions as CoA to many NRs, including PPARs and 
VDR (Liang and Ward, 2006; Savkur et al., 2005). It does not possess HAT activity itself, but is 
able to recruit HATs, such as CBP and p300, as well as the hSWI/SNF-remodeling complex via 
its BAF60a subunit (Li et al., 2008; Liang and Ward, 2006). 
Both lysine-specific HMTs, such as G9a, SET7/9 and MLL, and arginine-specific HMTs, such as 
PRMT1 and CARM1, have been shown to interact with NRs (Subramanian et al., 2008). The 
function of these co-factors on NR-regulated transcription remains quite poorly defined. In a 
study on ER, SET7/9, the lysine methyltransferase that methylates histone H3 at lysine 4, was 
shown to methylate ER, leading to more stable receptor, increased recruitment to target genes as 
well as increased transactivation potential (Subramanian et al., 2008). CARM1 methylates 
histone H3 at arginine 2, 17 and 26 and co-operates with HATs and chromatin remodeling 
complexes to enhance transcriptional activation by NRs. However, it still remains unclear, to 
which extent the co-operation depends on methylation of histone residues, since CARM1 also 
methylates NCOAs. Methylation of NCOAs leads to both increased activation and, paradoxically, 
to disassembly of the CoA complex (Feng et al., 2006). 
Lysine demethylation by the lysine-specific histone demethylase 1 (LSD1, encoded by AOF2 
gene) has been linked to both repression and activation of genes. LSD1 catalyzes the 
demethylation of both the activity-linked H3K4me1/2 and the repression-linked H3K9me, 
although the latter activity has not been detected in vitro (Forneris et al., 2008). LSD1 was 
originally identified from a repressor complex and thus identified as a CoR (Forneris et al., 
2008). However, in a genome-wide analysis, LSD1 was shown to occupy 20 % of all promoters, 
84 % of which were associated with Pol II and histone modifications typical for transcriptionally 
active regions, such as H3K4me2, indicating a role as a CoA (Garcia-Bassets et al., 2007). LSD1 
is also essential for AR-induced gene expression and H3K9me1/2 demethylation, whereas the 
JMJC domain-containing protein is needed for the removal of the trimethylation modification of 
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H3K9 (Wissmann et al., 2007). LSD1 seems also to play an important part in NR ligand-induced 
chromatin looping, which is discussed in more detail in a following section. 
Chromatin remodeling complexes contain an ATP-dependent DNA helicase / ATPase that 
induces or represses transcription by using the energy of ATP to dissociate core histones, slide 
nucleosomes or relocate entire histone octamers within the chromatin structure. These remodeling 
complexes are divided into four major sub-families based on their central catalytic subunit: the 
SWI/SNF, ISWI, CHD/Mi-2 and INO80 complexes with BRG1/hBRM, hSNFL2/hSNF2h, 
CHD1/CHD3/CHD4 and SCRAP/p400 as catalytic units, respectively (Lall, 2007). The 
components of the sub-families can also form joint multi-complexes, such as the WSTF including 
nucleosome assembly complex (WINAC), which includes members of the hSWI/SNF and ISWI 
complexes and promotes both the assembly and disruption of nucleosomal structure in an ATP-
dependent manner via BRG1 and hBrm (Trotter and Archer, 2008). The WINAC complex is able 
to interact ligand-dependently with VDR via the WSTF component and activates and represses 
gene transcription by creating either an open or a closed chromatin structure (Kitagawa et al., 
2003). VDR has also been shown to associate with the PBAF and hSWI/SNF complexes in vitro, 
and in repressive role with the hSNF2 complex (Ewing et al., 2007; Lemon et al., 2001). The 
rationale for chromatin remodeling in transcription was illustrated by in vitro transcription 
reactions performed by Lemon and colleagues (Lemon et al., 2001). In their studies, the 
component of the basal transcription machinery, TFIID, and the Mediator complex were essential 
and sufficient for transcriptional activation by VDR-RXR heterodimers on naked DNA, where 
the ligand and ATP-dependent chromatin remodeling complex PBAF completely lacked effect. In 
transcription from chromatin, however, the remodeling complex PBAF was essential in addition 
to TFIID and the Mediator complex with immense induction by ligand. This assay suggests that 
the chromatin structure restrains transcription by the basal transcriptional machinery and the 
Mediator complex, but that this obstacle can be overcome by chromatin remodeling that is 
activated by liganded NRs. 
VDR can also modify transcription in events subsequent to initiation of transcription. SNW 
domain containing 1 (SNW1, also called NCOA-62 or SKIP) is a CoA that can bind to the LBD 
of VDR and retinoic acid receptors (RARs) to enhance ligand-mediated gene expression 
(MacDonald et al., 2004). SNW1 interacts with the spliceosome and expression of a dominant 
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negative SNW1 resulted in a ligand-dependent transient accumulation of un-spliced transcripts 
generated from a 1α,25(OH)2D3-responsive mini-gene cassette (Zhang et al., 2003). Therefore, 
SNW1 may couple regulation of transcription by VDR to splicing and thus determining the 
overall response of ligand-regulated genes. 
2.1.4.2 Co-repressors 
CoRs can be classified according to their function to basal CoRs, such as NCoR1 or SMRT, that 
function as platforms for the recruitment of several sub-complexes that often contain HDAC 
activity, ATP-dependent chromatin remodeling complexes and other CoRs that recruit general 
CoRs upon ligand induction, such as the ligand dependent nuclear receptor corepressor (LCoR) 
and NR interacting protein 1 (NRIP1 or RIP140) (Perissi and Rosenfeld, 2005). 
In the absence of ligand NRs, such as thyroid hormone receptors (TRs), RARs and VDR, reside 
in the nucleus and interact with basal CoR complexes containing the NCoR1 or SMRT, which 
mediate repression by deacetylation of histones. The complex for either of them contains 
HDAC3, transducin-β-like 1 (TBL1 encoded by the TBL1X gene), TBL1 receptor 1 (TBL1R1 
encoded by the TBL1XR1 gene), G protein pathway suppressor 2 (GPS2) and coronin, actin 
binding protein, 2A (CORO2A or IR-10) (Yoon et al., 2003). In the complex NCoR1 and SMRT 
serve as docking sites between NRs and the CoR complex and are also required for the HDAC 
activity of HDAC3 (Guenther et al., 2001). Although other HDACs have been connected to the 
complex, HDAC3 is essential at least for the repression by un-liganded TR (Yoon et al., 2003). 
TBL1/TBL1R1 are essential for the recruitment of the ubiquitin conjugating/19S proteasome 
complex, where TBL1R1 selectively mediates the exchange of the NCoR1/SMRT complex to 
CoAs upon ligand binding, and they are also essential in targeting the CoR complex to hypo-
acetylated chromatin (Perissi et al., 2004; Yoon et al., 2005). Of the remaining complex subunits, 
CORO2A has homology to actin-binding proteins, and thus may serve in repositioning the target 
chromatin inside the nucleus. The GPS2 subunit may serve as a link between NR and cellular 
signaling pathways, as GPS2 inhibits the transcription activation potential of the c-Jun N-terminal 
kinase 1 (JNK1) pathway (Zhang et al., 2002). The role of NCoR1/SMRT complexes is not only 
restricted to deacetylation, since recently NCoR1 was shown to recruit a H2A ubiquitin ligase 
Review of the literature 
Kuopio Univ. Publ. C. Nat. and Environ. Sci. 246: 1-100 (2008) 31 
that inhibits the elongation by Pol II beyond the first nucleosome of the transcribed region (Zhou 
et al., 2008). 
HDACs are an important group of effectors in NR-mediated repression of gene transcription, 
forming a counterforce to HATs. There are currently 18 known mammalian HDACs, grouped 
into four classes based on sequence similarity: class I HDACs include HDAC1, 2, 3 and 8, class 
II HDACs include HDAC4, 5, 6, 7, 9 and 10, class III refers to seven unrelated sirtuin 
deacetylases, whereas HDAC11 alone forms the class IV (Gallinari et al., 2007). In addition to 
the permanent subunit HDAC3, NCoR1/SMRT complex interacts with class II HDACs. 
However, the HDAC activity of HDAC4 and HDAC5 depends on presence of HDAC3 in a 
repressor complex (Fischle et al., 2002). The HDAC activity of purified class II HDACs is low in 
vitro, suggesting that their main role is deacetylation of non-histone targets rather than of 
histones. Interestingly, HDAC3 and HDAC4 were shown to bind NRs also directly and 
independently of the CoR complex in vitro, but the in vivo relevance of this finding remains 
unclear (Franco et al., 2003). Despite the broad role of HDACs in repression, the use of HDAC 
inhibitors leads to induction of bulk levels of histone acetylation, but to very limited 
transcriptional response with equal numbers of genes activated and repressed by HDAC 
inhibition (Smith, 2008). HDACs may modulate transcription via deacetylation of transcription 
factors and CoAs in addition to histones. As acetylation of a protein may either increase or 
decrease its activity, the net transcriptional outcome of deacetylation of non-histone targets may 
be activation as well as repression. 
In addition to NCoR1/SMRT, Hairless and Alien have been reported to be VDR-associated CoRs 
(Tagami et al., 1998; Polly et al., 2000a; Hsieh et al., 2003). Also NRIP1 has been shown to 
associate with VDR (Masuyama et al., 1997). Interestingly, NRIP1 and LCoR can bind to NRs in 
a ligand-dependent manner and compete with CoAs by displacing them. However, the latter 
phenomenon has not been characterized with VDR bound CoRs (Perissi and Rosenfeld, 2005). 
The nucleosome remodeling complex with strongest association to repression is NuRD, which 
possesses HDAC1 and 2 in addition to the ATP-dependent chromatin remodelers CHD3 or 
CHD4. The complex is recruited to chromatin by sequence-specific transcription factors, such as 
un-liganded RAR and TR and/or the MBD2 protein, which binds to methylated DNA (Crook et 
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al., 2006). The importance of this complex in creation and maintenance of repressed chromatin is 
illustrated by knockdown of its components, which impaired histone deacetylation, chromatin 
compaction, DNA and histone methylation as well as stable silencing, favoring cellular 
differentiation of leukemic cells (Morey et al., 2008). The repression of target genes by un-
liganded VDR has been shown to be dependent on the bromodomain adjacent to the zinc finger 
domain, 1A (BAZ1A or hAcf1), which is a part of the hSNF2h chromatin remodeling complex 
and improves the ability of this complex to mobilize nucleosomes (Ewing et al., 2007). BAZ1A 
directly associates with NCoR1 and stabilizes both the CoR complex association and repressive 
chromatin architecture at selected 1α,25(OH)2D3 target gene promoters. These studies suggest 
that ATP-dependent nucleosome remodeling is an essential part of repression by NRs, possibly 
via establishing and maintenance of repressive chromatin and inhibition of nucleosome eviction 
from target promoters. 
2.1.5 Role of chromatin in NR-mediated transcription 
2.1.5.1 Histone modifications 
Both DNA and histones on the chromatin structure can be modified and increasing evidence 
supports the idea that these modifications serve as specific signals for chromatin binding proteins, 
i.e. that the modifications form a ‘histone code’ read by associated factors (Strahl and Allis, 2000; 
Turner et al., 1992). The modifications include DNA methylation, variant isotypes of the core 
histones themselves and various covalent modifications of N-terminal tails of core histones. The 
modifications of the tail residues include acetylation (ac), mono-, di- or trimethylation 
(me/me2/me3), ubiquitylation (ub) or sumoylation (su) of lysines (K), mono- or dimethylation 
(me/me2) or citrullination (cit) of arginines (R) and phosphorylation (phos) of serines (S) and 
threonines (T) (Ruthenburg 2007, Lall 2007).  
As yet, we are far from fluent reading of the histone code, but we can try to approach it by 
defining, in which processes the modifications are involved, which proteins bind them and which 
proteins can alter them. The reading of the code is further complicated by the different 
combinations of modifications, which lead to distinct outcomes (Fischer et al., 2008; Garske et 
al., 2008). As an example of a single modification, H3K4me2, on a genome-wide scale, is 
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enriched to approximately the 1 kbp area around active TSSs and within active enhancer regions 
(Barski et al., 2007; Heintzman et al., 2007). H3K4me2 is bound by several chromodomain or 
plant homeodomain (PHD) containing proteins, such as the ATP-dependent chromatin-
remodeling factor chromodomain helicase DNA binding protein 1 (CHD1) that can alter the 
accessibility of DNA for transcription (Pray-Grant et al., 2005), the inhibitor of growth family, 
member 2 (ING2), which is part of a transcriptionally repressive complex (Peña et al., 2006) and 
bromodomain PHD finger transcription factor (BPTF), which is part of the ATP-dependent 
chromatin-remodeling complex (Li et al., 2006). Methylation of H3K4 also prevents the binding 
of the CoR complex NuRD to the histone H3 tail (Zegerman et al., 2002). These binding partners 
indicate important regulatory functions for this modification, such as induction of chromatin 
remodeling needed for transcription initiation and, paradoxically, potential repression of gene 
expression by histone deacetylation.  
Another example of modification linked to transcriptional activity is H3K9ac, which is also 
enriched close to TSSs and enhancers and is induced upon activation of transcription (Garcia-
Bassets et al., 2007; Heintzman et al., 2007). It is bound by bromodomain containing proteins 
that recognize this specific acetylated residue, such as the HAT CBP that acetylates H3K14 and 
TAF1, a subunit of the general transcription factor TFIID (Agalioti et al., 2002; Zeng et al., 
2008). Interestingly, acetylations at H3K9 and H3K14 are both essential for the recruitment of 
TAFIID in an in vitro model with mutant histones, pointing out a key role for H3K9ac as an 
initial signal for the assembly of transcriptional machinery (Agalioti et al., 2002). 
2.1.5.2 Chromatin looping 
Since the establishment of the chromosome conformation capture (3C) assay by Dekker and 
colleagues (Dekker et al., 2002), chromatin looping has been widely studied as a mode of 
interaction between genomic elements distal to each other. The bending of chromatin provides a 
physical contact between NRs residing on REs and the basal Pol II machinery bound to the TSS 
of target genes, enabling transcriptional activation from distal REs. As the method is still quite 
new, the mechanisms that mediate chromatin looping remain poorly understood. Recently, Perillo 
and colleagues suggested a molecular basis for the formation of chromatin loops involving 
histone demethylation (Perillo et al., 2008). Based on their studies with the ERα, they propose a 
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model, where chromatin-bound liganded receptor induces demethylation of H3K9me2 by the 
lysine demethylase LSD1. A side product of this demethylation is the strictly local production of 
hydrogen peroxide, which, in turn, oxidizes DNA to 8-oxo-guanine. This is then recognized and 
removed by base excision repair enzymes. The resulting single-stranded DNA breaks are 
subsequently recognized by topoisomerase IIb that acts to relax DNA strand topology, enabling 
the bending of chromatin to form loops between enhancers and the transcription initiation 
complex. In addition to relaxation of chromatin, the reactive oxygen species (ROS) produced by 
LSD1 inhibit proteasome activity and hence ERα degradation. ROS was also shown to be 
essential for accumulation of phosphorylated Pol II to target gene promoters. Transcription cycles 
could then be set to pace by local ROS concentrations that enable both the flexibility of the DNA 
strand and timely degradation of the NR as ROS concentration reduces without new 
demethylation events. It still remains a mystery, though, whether increased flexibility of DNA 
leads to increased random movement and hence to increased chance for the factors on enhancers 
and on TSS to encounter and bind to each other, or whether looping requires an active network 
that brings the elements together, such as a hypothetical dynamic nuclear matrix directed by 
ATP-dependent chromatin remodeling complexes (Varga-Weisz and Becker, 2006). 
2.1.6 Models for NR-induced gene expression 
In vitro, binding of a ligand to a NR induces a structural change in the receptor that favors 
interactions with CoAs instead of CoRs bound by an unliganded receptor. The application of 
these in vitro results to depict the situation in vivo lead to the on/off model, where an agonistic 
ligand acts as a switch between CoR and CoA recruitment. This model has restrictions in vivo. 
For instance, it does not provide an explanation for the termination of transcription. With kinetic 
data from chromatin immuno-precipitation (ChIP), the on-off model has been replaced by a 
cyclical one, where the NR, CoAs and CoRs are recurrently recruited to and released from the 
target promoter in an ordered manner to repeatedly first induce and then limit transcription of 
responsive genes (Metivier et al., 2003; Shang et al., 2000). The release from the promoter is 
suggested to occur via proteasomal degradation and/or chaperone-mediated disassembly of the 
regulators (Reid et al., 2003; Freeman and Yamamoto, 2002; Bikle et al., 2007). In addition to 
the dynamics of transcription regulators, the role of chromatin modifications and conformation as 
well as the dynamics of both has become an issue of interest. Already the first cyclical models 
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included recurrent changes in histone acetylation, and since then a ligand-dependent cyclical 
response in DNA methylation via DNA methyltransferases has been introduced (Metivier et al., 
2008).  
 
2.2 Cyclin-dependent kinase inhibitor p21 
2.2.1 Functions of p21 
2.2.1.1 Regulation of cell cycle by cyclin-dependent kinase inhibitors 
In multi-cellular organisms, the division of cells is tightly controlled by protein-kinases of the cell 
cycle machinery that are regulated by extraneous signals such as growth factors, enabling co-
ordinated division of individual cells to meet the needs of the organism as a whole. A signal to 
proliferate, such as growth factor stimulation, allows a quiescent cell to re-enter the cell cycle at 
G0/G1, after which, in the absence of disturbances, damage or stress, the rest of the cell cycle is a 
highly co-ordinated but nonetheless automatic process (Pajalunga et al., 2008). Growth factors 
induce the expression of D-type cyclins, which form complexes with cyclin-dependent kinases 
(CDKs) 4 or 6 to phosphorylate the pocket proteins retinoblastoma 1 (Rb, encoded by RB1), p107 
and p130 at multiple amino acid residues. This releases E2F family transcription factors, which 
activate the expression of numerous effectors of DNA synthesis. E2F factors also drive 
expression of cyclin E, which activates CDK2 to further phosphorylate the pocket proteins and, in 
a kinase-independent manner, loads MCM helicase complexes onto DNA replication origins 
(Geng et al., 2007). The cyclin-CDK complexes are inhibited by proteins of the family of cyclin-
dependent kinase inhibitors (CDKIs), composed of the INK4 sub-family including p15 (INK4B, 
encoded by the human gene CDKN2B), p16 (INK4A, encoded by the CDKN2A gene), p14 (ARF, 
also encoded by the CDKN2A gene), p18 (INK4C, encoded by  the CDKN2C gene) and p19 
(INK4D, encoded by the CDKN2D gene), and the Cip/Kip family with p21 (WAF1/Cip1 encoded 
by the CDKN1A gene), p27 (Kip1, encoded by the CDKN1B gene) and p57 (Kip2 encoded by the 
gene CDKN1C). The members of the INK4 family specifically bind and inhibit the CDKs 4 and 
6, thus blocking the entry to the S phase, whereas CIP/KIP inhibitors bind to both cyclin and 
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CDK subunits and can modulate the activities of cyclin D-, E-, A-, and B-CDK complexes 
(Pajalunga et al., 2008). 
In addition to their inhibitory function for CDK activity, the role of p21 and p27 is complicated 
by their function as a bridge between cyclin D and CDK4 to promote their association and 
nuclear translocation (Coqueret, 2003). In the nucleus cyclin-D-CDK complexes titrate p21 and 
p27 from CDK2, which leads to cell cycle progression. When the amount of CIP/KIP proteins 
increases to a saturated level, they bind to cyclin-E-CDK2, in order to block the catalytic activity 
of the kinase and cause cell-cycle arrest. CDK2 is dispensable for cell cycle arrest at the G1-S 
transition and in CDK2-/- cells p21 induces cell cycle arrest via inhibition of CDK1 
(Satyanarayana et al., 2008). A further complication to the system is provided by an assembly 
factor of the pre-replicative complex Cdc6, which is able to activate CDK2 despite the presence 
of active p21 (Kan et al., 2008). 
2.2.1.1.1 p21, p16 and senescence 
Senescence is the physiological process of terminal growth arrest, accompanied by specific 
changes in cell shape, adhesion and gene expression. It can be divided into replicative 
senescence, mediated primarily by telomere shortening, and accelerated senescence that occurs in 
response to DNA damage or introduction of oncogenic RAS and permanently stops the 
proliferation of cells with potentially carcinogenic damage (Roninson, 2002). DNA damage or 
telomere shortening beyond a critical length activates p53, leading to a transient peak in p21 
expression. After the peak, p21 expression settles to a slightly induced level, whereas p16 
becomes constitutively upregulated, presumably via stress-related MAPK pathways and 
maintains terminal growth arrest by quenching CDK4/6 activity (Herbig and Sedivy, 2006; 
Roninson, 2002). Overexpression of either p21 or p16 induces senescence both in normal and 
malignant cells in an Rb-dependent manner, confirming that the senescence promoting function 
of these CDKIs is a consequence of the cell cycle block (Chen et al., 2006). Induction of 
senescence does not require activity of both CDKIs, as overexpression of p21 with knockdown of 
p16 and vice versa also leads to increased senescence. There is also a downside of the senescence 
promoting function of p21, as p21 gene knockout prolongs the lifespan of telomerase knockout 
mice (with dysfunctional telomeres) and improves stem cell function when compared to wild type 
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p21 gene expressing littermates, but not in telomerase expressing mice (Choudhury et al., 2007). 
Although p21 gene deletion did not induce chromosomal instability or cancer formation in mice 
lacking telomerase, p21 gene deletion induced both the number of transformed foci in oncogene-
transfected mouse embryonic fibroblasts and macroscopic tumor incidence in mice with 
heterozygous telomerase expression. 
2.2.1.2 Anti- and pro-apoptotic p21 functions 
Both overexpression and deletion of p21 have been shown to sensitize cells towards apoptosis. 
For example, overexpression of the p21 gene enhances apoptosis in response to cisplatin in 
glioma and ovarian carcinoma cell lines, potentiates bile acid-induced MAPK-dependent 
apoptosis in hepatocytes, induces pro-apoptotic BAX in presence of C6-ceramide and sensitizes 
granulocytes to differentiation-induced apoptosis (Gartel, 2005). Conversely, p21 has been shown 
to protect cells from apoptosis, since the protein blocks the processing of pro-caspase-3 into its 
active form, which, in turn, can cleave and thus inactivate p21 (Levkau et al., 1998; Suzuki et al., 
1998). The CDK inhibition activity of the p21 protein itself may inhibit apoptosis, because CDK 
activity may be essential for an efficient activation of the caspase cascade (Besson et al., 2008). 
Moreover, cytosolic p21 protein interferes with apoptosis-linked mitogen-activated pathways, 
e.g., by inhibition of a death receptor target and the pro-apoptotic MAPK kinase kinase 5 
(MAP3K5 or ASK1) via direct binding and of stress-activated protein kinases (Asada et al., 
1999; Shim et al., 1996). In some cases the anti-apoptotic function of the p21 protein is a 
consequence of its growth-inhibitory function. For example, the increased apoptosis with DNA-
damaging agents or anti-microtubular drugs in cells lacking a p21 gene may be merely a 
consequence of lack of DNA repair prior to mitosis, leading to mitotic catastrophe and finally 
apoptosis (Roninson, 2002). 
2.2.1.3 p21 in DNA repair and replication 
The proliferating nuclear antigen (PCNA) is a co-factor of DNA polymerases that encircles DNA 
and tethers polymerases firmly to it, increasing the processivity of DNA polymerases from tens to 
thousands of nucleotides per minute (Moldovan et al., 2007). Apart from playing an essential role 
in DNA replication it is also involved in DNA synthesis during UV-induced nucleotide excision 
repair (NER) (Montecucco et al., 1998). Direct binding of the p21 protein to PCNA inhibits DNA 
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replication in vitro and in vivo by blocking the activity of PCNA to stimulate DNA polymerases, 
although the role of the p21 protein in DNA repair remains controversial (Moldovan et al., 2007). 
Human fibroblasts lacking a p21 gene are more sensitive to UV-induced DNA damage and show 
defects in NER, with prolonged PCNA association on the DNA repair sites (Stivala et al., 2001). 
On the other hand, the p21 protein bound to PCNA inhibits NER in vitro. In vivo accumulation of 
endogenous p21 protein also inhibits NER. The inhibition of NER in cells lacking growth arrest 
and DNA-damage-inducible α (GADD45A) gene or a gene encoding subunit of the damaged-
DNA-binding protein DDB, DDB2, is restored by the inhibition of p21 gene transcription 
(Stoyanova et al., 2008). Whether with positive or negative role on NER, p21 protein is 
immediately recruited to DNA damage sites, together with repair factors, such as DNA 
polymerase δ, XPG and CAF-1 (Perucca et al., 2006). A recent model suggested a positive role 
for p21 in NER and included interactions with PCNA and p300 (Cazzalini et al., 2008). The HAT 
activity of p300 may provide chromatin accessibility to the NER machinery on the non-
transcribed regions, however, paradoxically, PCNA inhibits the HAT activity of p300. DNA 
damage induces PCNA recruitment to regions harvesting p300, with subsequent recruitment of 
p21 that leads to disruption of association of PCNA and p300, thus promoting accessibility of 
PCNA-dependent NER machinery in surrounding chromatin regions. 
2.2.1.4 Transcriptional control by p21 
In addition to indirect modulation of E2F transcription factors via regulating pocket protein 
phosphorylation, CIP/KIP proteins can also modulate the activity of transcription factors via 
direct binding. For example, the p21 protein is recruited to the promoters of the human MYC and 
CDC25A genes, the latter of which encodes for a phosphatase that activates Cdc2. It is essential 
for progression from G1 to the S phase and, together with the STAT3 and E2F1 transcription 
factors, leads to reduced expression of target genes (Vigneron et al., 2006). The p21 protein also 
binds to the product of the MYC gene, myc, thereby blocking myc-MAX complex formation and 
subsequently suppressing the transcriptional activation by this complex (Kitaura et al., 2000). On 
the other hand, p21 protein can modulate p300/CBP HAT complex-mediated transcriptional 
activation via binding to p300, which disrupts the activity of the transcriptional-repression 
domain of p300 and de-represses transcription of target genes (Garcia-Wilson and Perkins, 2005). 
Recently, this CDKI was found to directly interact with un-liganded ERα in a complex that 
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includes also CDK2 and cyclin E (Maynadier et al., 2008). Loss of the p21 gene abolished the 
growth inhibition by un-liganded ERα, although the mechanism of the action of this complex is 
unclear as the ability of ERα to bind DNA is not needed for the growth inhibitory response. 
2.2.1.5 Knockout models of Cip/Kip family members 
Despite the similar binding preferences to cyclins and CDKs shared by the Cip/Kip family of 
CDKIs, they respond to distinct anti-proliferative signals and are involved in different 
physiological pathways. DNA damage leads to activation of p53 that directly binds to the p21 
gene promoter and up-regulates its transcription, whereas p27 gene expression is induced in 
quiescent cells lacking mitogenic signals and p27 protein is rapidly degraded as cells reenter the 
cell cycle (Besson et al., 2008). On the other hand, p57 is mainly expressed during 
embryogenesis and regulated by embryogenic transcription factors, such as Notch/Hes1, MyoD, 
BMP-2 and -6. Knockout of the Cip/Kip family member genes in model organisms further 
illuminate their distinct physiological roles. p27 gene null mice have an increased body size and 
multiple organ hyperplasia, as the p27 protein is essential in limiting growth. Mouse embryos null 
for the p57 gene also have organ hyperplasia and delayed differentiation but die at birth, 
confirming p57 as an essential regulator of embryonic growth (Besson et al., 2008). Mice lacking 
p21 develop normally, although p21-/- murine embryonic fibroblasts are deficient in their ability 
to arrest in G1 in response to DNA damage and show aberrant growth achieving a higher 
saturation density than wild-type cells (Deng et al., 1995).  
2.2.1.6 Bivalency of p21 in tumorigenesis 
The role of p21 in tumorigenesis appears controversial, suggesting both tumor suppressive and 
oncogenic functions for its product. Although p21 null mice are susceptible to spontaneous 
tumors of hematopoietic, endothelial and epithelial origin at an average age of 16 months, loss of 
p21 delays tumor development in ataxia-telangiectasia, mutated negative (ATM-/-), p53-/- or 
irradiated wild-type mice, presumably due to the anti-apoptotic activity of p21 (Martin-Caballero 
et al., 2001). Moreover, PDGF-induced gliomagenesis is dramatically reduced in mice lacking 
the p21 gene, because the p21 protein induces the nuclear localization of cyclin D1. Inactivating 
mutations of the p21, as well as the p27 gene, are exceedingly rare. While loss of the p21 gene is 
a negative prognostic marker in some cancer types, it appears that overexpression or cytoplasmic 
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localization of p21 is a marker of poor prognosis and aggressive tumors in carcinomas of the 
pancreas, breast, prostate, ovary and cervix, as well as in glioblastomas. These results suggest 
that, while nuclear p21 protein acts as a tumor suppressor by the induction of G1 arrest, 
cytoplasmic p21 is oncogenic. Indeed, phosphorylation of p21 by the proliferative kinases 
PKB/Akt and PKC promotes cytoplasmic localization. The phosphorylation status of the p21 
protein also modifies the outcome of the interaction with cyclin-CDK complexes. For example, 
phosphorylation of p21 by CDK2 converts it from an inhibitory subunit to a positive regulatory 
factor that assists cyclin B1-CDK1 activation at the G2/M phase, thus accelerating the progression 
of the cell cycle (Dash and El-Deiry, 2005). 
2.2.2 Regulation of p21 expression 
The major transcription factor regulating p21 expression is the tumor suppressor protein p53 
(encoded by the TP53 gene) that mediates the information of DNA damage to a cell cycle block 
via direct transcriptional activation of the p21 gene to prevent replication of damaged DNA. The 
damaged DNA is recognized either by the MRE11–RAD50–NBS1 (MRN) complex that recruits 
and activates ATM and Rad3-related (ATR) and ATM kinases, or by the kinases themselves. The 
kinases in turn activate the p53 protein by direct phosphorylation on the serine at position 15 and 
by activating the CHK2 kinase, which further phosphorylates p53 at another serine at position 20 
(Cann and Hicks, 2007). These phosphorylations interrupt association of p53 with its negative 
regulator mouse double minute 2 homolog (MDM2), an ubiquitin ligase that both sterically 
blocks the transcriptional activity of p53 and mediates the degradation of the p53 protein. As a 
result from the phosphorylations, the half-life of the p53 protein is increased from minutes to 
hours (Riley et al., 2008). ATM can also initiate a phosphorylation cascade that leads rapidly to 
CDK2 protein inactivation. The acetylation and methylation of p53 by HATs (CBP, p300, PCAF) 
and methyltransferases (SET9), respectively, can further stabilize the protein by inhibiting 
interactions with MDM2 and increase its affinity for DNA.  
The p53 tetramer binds to specific REs with two or more RRRCWWGYYY (R = A or G, W = A 
or T, Y = C or T) half-sites in various orientations, separated by 0 to 21 spacer nucleotides (Riley 
et al., 2008). The co-factors involved and the mechanisms of transcription activated by p53 
resemble those of NRs, with HATs (p300, CBP), arginine methyltransferases (CARM1 and 
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PRMT1), the lysine demethylase LSD1, HDACs, chromatin remodelers (hSWI/SNF via BAF60) 
and the MED1 subunit of the Mediator complex acting to promote transcription (An et al., 2004; 
Huang et al., 2007; Donner et al., 2007; Oh et al., 2008). There are also differences between p53- 
and NR-mediated transcription, such as protein stabilization of p53 versus ligand activation of 
NRs, the ability of p53 to recruit the p300/CBP HAT complex directly through the same domain 
in CBP that is bound by NCOA1 in the NR response, and finally, a shortage of reported contacts 
between p53 and primary NR co-factor complexes, such as NCoR1/SMRT or NCOAs 
(Livengood et al., 2002). 
Several members of the Sp/Krüppel-like factor (KLF) family of transcription factors, such as 
Sp1, Sp3, KLF2, KLF4, KLF5, KLF6 and KLF7, induce p21 gene transcription via binding to 
common GC-rich sequences termed as GC-boxes at proximal promoter of p21 (Rowland and 
Peeper, 2006). The six GC-boxes of the p21 gene promoter are crucial for both basal and induced 
p21 gene transcription, as mutation of a selected GC-box abolished the activity of a 2.3 kbp p21 
gene promoter construct, and knockdown of Sp1 greatly decreases p21 protein levels in a p53-/- 
genetic background (Cen et al., 2008; Koutsodontis et al., 2002). Sp proteins interact with a wide 
variety of transcriptional regulators, such as NRs, E2F transcription factors, NCoR1/SMRT 
CoRs, HATs and other chromatin modifiers. Sp proteins are considered as constitutively active, 
but their activity is also regulated by post-translational modifications from cell signaling 
pathways, such as phosphorylation by the epidermal growth factor-activated MAP kinase, ERK2, 
or DNA damage-activated kinase ATM (Iwahori et al., 2008; Merchant et al., 1999). It has been 
suggested that one mechanism for HDAC inhibitors is modulation of Sp1 activity via increased 
acetylation as opposed to unspecific de-repression of chromatin (Huang et al., 2005; Lee et al., 
2005).  
As the p21 protein is an important regulator of cell proliferation, its expression is under direct 
regulation of several cellular pathways that either promote or in inhibit proliferation. For 
example, the Notch and TGF-β/Smad3/4 pathways counteract each other on multiple CDKI gene 
promoters, where Notch and Smad3 are enriched to a shared chromatin template and inhibit each 
other’s binding (Carlson et al., 2008). Notch inhibits CDKI gene expression and promotes muscle 
stem cell regeneration in young muscle, whereas mainly TGF-β is expressed in old muscle, with 
Smad3 activating CDKI gene expression that leads to block in muscle stem cell regeneration. 
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Thus, increased expression of CDKI protein is linked to senescence on the whole organism level 
through inhibition of stem cell regeneration, which compromises normal tissue maintenance. 
Several NRs, such as Hepatocyte nuclear factor 4α (HNF4α), ERRβ, AR, RARs, RXRs, REV-
ERBα /β, RAR-related orphan receptors α and γ (RORα and -γ), and VDR have been shown to 
associate with regulatory regions of the mammalian p21 gene and modulate its expression (Lu et 
al., 1999; Tanaka et al., 2007; Yu et al., 2008; Hwang-Verslues and Sladek, 2008; Grechez-
Cassiau et al., 2008). For many NRs, including HNF4α, PPARγ and progesterone receptor, the 
association with the p21 gene promoter and/or modulation of p21 expression has been suggested 
to occur via Sp proteins (Owen et al., 1998; Han et al., 2004; Hwang-Verslues and Sladek, 2008). 
This may partially be an artifact, as Sp REs reside close to the TSS, which may be occupied by 
the NRs in ChIP assays via chromatin looping, and lack of REs may result from restrictions in the 
promoter area searched and/or the in silico method used.  
The transcription factor myc inhibits the expression of the p21 gene via interaction with either 
Sp1 or Miz-1, both of which up-regulate p21 gene transcription in absence of myc (Gartel and 
Radhakrishnan, 2005). As for Sp1-mediated repression, myc reduces the transcriptional activity 
of Sp1 without influencing its binding to the p21 gene promoter, whereas Miz-1-mediated 
repression depends on DNA methylation by the DNA methyltransferase Dnmt3, that also forms a 
complex with myc and Miz-1 (Brenner et al., 2005; Vaque et al., 2005). Additionally, the 
ubiquitously expressed YY1 transcription factor (YY1) downregulates p21 gene expression via 
association with Sp1, although in vitro YY1 can bind directly to the distal p53 RE of the p21 
gene promoter (Santiago et al., 2007; Yakovleva et al., 2004). In addition, YY1 induces p53 
degradation by stimulating MDM2-mediated p53 ubiquitination via a direct physical interaction 
(Sui et al., 2004). YY1 is able to repress transcription via interaction with the 
NCoR1/Sin3A/HDAC3 complex, as well as via HDACs 4 and 5 (Le May et al., 2008; Sucharov 
et al., 2008; Wang et al., 2008). YY1 also attenuates 1α,25(OH)2D3-responsive transcription 
either by binding to YY1 RE within VDREs or by sequestering the CoAs TFIIB and CBP from 
VDR (Guo et al., 1997; Raval-Pandya et al., 2001). 
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2.2.3 Regulation of cell cycle by 1α ,25(OH)2D3 
The main anti-proliferative effect of 1α,25(OH)2D3 on cells is cell cycle block at the G1 phase. 
This can be explained by changed expression of multiple cell cycle regulator genes. Among the 
first targets described, expressions of the p21 and p27 genes were found to be upregulated by 
ligand treatment (Jiang et al., 1994; Wang et al., 1996). For the p21 gene a VDRE on the 
proximal promoter was characterized, thus establishing p21 as a direct 1α,25(OH)2D3 target gene 
(Liu et al., 1996b). Later on it has been questioned, whether p21 truly is a primary target gene or 
a secondary target via up-regulation of TGF-β or of the insulin-like growth factor binding protein 
3 (IGFBP3), and whether the described VDRE is truly functional (Danielsson et al., 1997; 
Verlinden et al., 1998; Boyle et al., 2001). The credibility of the p21 gene as the anti-proliferative 
target of 1α,25(OH)2D3 has also been eroded by studies showing lack of induction of p21 
expression upon to 1α,25(OH)2D3 exposure, and the demonstration that 1α,25(OH)2D3 has anti-
proliferative effects also in p21 knockdown cells (Akutsu et al., 2001; Wade et al., 2002; 
Ryhänen et al., 2003). However, siRNA against the p21 transcript abolished the growth inhibition 
of LNCaP malignant prostate cells by 1α,25(OH)2D3, thereby supporting the role of p21 as an 
important anti-proliferative target of 1α,25(OH)2D3 (Rao et al., 2004). 
In general, the regulation of the quantity of the p27 occurs via protein stabilization and this is 
how 1α,25(OH)2D3 appears to increase this protein’s abundance as well. Firstly, 1α,25(OH)2D3 
represses cyclin E gene expression. As a result, cyclin E cannot activate CDK2 to phosphorylate 
p27 on threonine 187, a modification needed for the binding of the ubiquitin ligase complex that 
includes S-phase kinase-associated protein 2 (p45) (SKP45). Secondly, 1α,25(OH)2D3 represses 
the transcription of SKP45 gene itself, thus inhibiting p27 degradation by the proteasome (Liu et 
al., 2002; Lin et al., 2003; Li et al., 2004). Also a transient mRNA response of p27 gene has been 
reported, but the significance of the transcriptional response as opposed to protein stabilization 
remains unclear (Muto et al., 1999). The importance of p27 as an anti-proliferative target of 
1α,25(OH)2D3 is as controversial as that of p21: ligand arrested only wild-type mouse embryo 
fibroblasts cells in the G1 phase, whereas p27 null cells were not arrested, although when 
immortalized, p27 null mouse embryo fibroblasts remain responsive to growth inhibition by 
1α,25(OH)2D3 (Li et al., 2004; Wade et al., 2002).  
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Other CDKIs, such as p15, p16, p18 and p19, show transcriptional response to 1α,25(OH)2D3, but 
for p16 the response is secondary as it can be blocked by inhibition of protein synthesis (Liu et 
al., 1996b; Tavera-Mendoza et al., 2006). In addition to the already mentioned repression of 
cyclin E, transcripts of cyclin D1 and CDK2 are downregulated by 1α,25(OH)2D3 (Alagbala et 
al., 2006; Verlinden et al., 1998). It remains to be elucidated, whether these effects are primary 
and occur via functional VDREs on the regulatory regions of these genes. On the other hand, the 
cyclin C transcript levels are induced by 1α,25(OH)2D3 and the cyclin C promoter has functional 
VDREs (Polly et al., 2000b; Sinkkonen et al., 2005). On protein level, 72 h treatment with 
1α,25(OH)2D3 analogs has been shown to downregulate cyclin C expression, whereas shorter 
treatment (4 to 12 h) with 1α,25(OH)2D3 induces cyclin C protein levels (Verlinden et al., 2000; 
Polly et al., 2000b). Cyclin C is linked to cell cycle regulation via binding to Cdk3 protein and to 
transcriptional regulation via binding to Cdk8 protein (Hoeppner et al., 2005). The complex 
formed by cyclin C and Cdk3 phosphorylates pRb at serine 807/811, and ectopic cyclin C 
expression promotes G0 exit (Ren and Rollins, 2004). The cyclin C –Cdk8 pair complex with 
MED12 and MED 13 form an accessory subcomplex of the Mediator, where Cdk8 inhibits PIC 
assembly via phosphorylation of the carboxy-terminal of the largest subunit of Pol II in vitro (Sun 
et al., 1998, Meyer et al., 2008). Cyclin C-Cdk8 complex also phosphorylates and inactivates 
cdk7-cyclin H subunits of the TFIIH complex (Akoulitchev et al., 2000). In complex with lysine 
acetyltransferase 2A (KAT2A, also called GCN5L), transformation/transcription domain-
associated protein (TRRAP) and the mediator subcomplex Cdk8 phosphorylates serine-10 of 
histone H3, which in turn stimulates H3K14 acetylation by KAT2A, and Cdk8 knockdown 
substantially reduces these histone modifications globally (Meyer et al., 2008). Interestingly, 
Cyclin C-Cdk8 complex also functions as a co-activator for p53: it induces the transcriptional 
activation potential of p53 as shown by reduced p21 mRNA upon CDK8 knockdown and 
increased the p21 promoter reporter gene construct activity upon ectopic Cyclin C and Cdk8 
expression (Donner et al., 2007). 
In addition to p21, also other p53 target genes, such as the GADD45A, members of the IGFBP 
gene family and MYC, also respond to 1α,25(OH)2D3 treatment (Simpson et al., 1987; Baudet et 
al., 1996; Colston et al., 1998; Akutsu et al., 2001; Prudencio et al., 2001; Pálmer et al., 2003; 
Matilainen et al., 2005; Ho et al., 2005). GADD45A plays an essential role in DNA repair and 
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GADD45 proteins also bind and inhibit Cdc2, displacing cyclin B1 and thus inhibit the formation 
of M phase-promoting factor that is essential for G2/M transition (Zhan et al., 1999). GADD45A 
has been shown to be a direct transcriptional target of 1α,25(OH)2D3 with a functional VDRE 
found in the fourth exon of the gene (Jiang et al., 2003). Jiang and colleagues also showed a 
specific role for GADD45 in regulation of the cell cycle, as GADD45 was essential for the G2/M 
block by 1α,25(OH)2D3, whereas its knockdown did not influence the ligand-induced G1/S block. 
IGFBPs modulate the activity of the circulating growth factors named insulin-like growth factors 
(IGF) I and II by sequestering them and may also regulate cell growth and apoptosis in an IGF-
independent manner (Meinbach and Lokeshwar, 2006). The IGFBP-3 gene was first discovered 
to be upregulated by 1α,25(OH)2D3 and contains a functional VDRE (Colston et al., 1998; Peng 
et al., 2004). Subsequently, the transcript levels of IGFBP-1, -2, -5 and -6 genes respond to 
1α,25(OH)2D3, of which functional VDREs have been characterized for IGFBP-1 and -5 (Pálmer 
et al., 2003; Matilainen et al., 2005). In LNCaP cells, IGFBP-3 was shown to be essential for the 
induction of p21 protein expression by of 1α,25(OH)2D3 (Boyle et al., 2001). A possible 
mechanism for the p21 response to IGFBP-3 is the activation of TGF-β/Smad pathway by 
IGFBP-3, as it induces phosphorylation of Smad2 and Smad3, which in turn are able to activate 
p21 gene expression (Baxter, 2001; Moustakas et al., 2002). MYC was one of the earliest found 
proliferation-associated targets of 1α,25(OH)2D3: the transcription rate of MYC decreases upon 
1α,25(OH)2D3 treatment (Simpson et al., 1987), however no VDREs have been characterized, as 
yet. Since 1α,25(OH)2D3 affects many regulators of MYC expression, such as the E-cadherin- β-
catenin–TCF4 pathway and the homeobox B4 transcription factor, indirect effects may contribute 
to downregulation of MYC by 1α,25(OH)2D3 (Pálmer et al., 2001; Pan and Simpson, 2001). 
Overall, 1α,25(OH)2D3 restricts cell cycle progression in several phases via multiple and partially 
redundant targets on parallel pathways, which when combined, provide robustness for the anti-
proliferative effect. 
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3. Aims of the Study  
1. To investigate whether p21 is a primary 1α,25(OH)2D3 target gene and whether VDR 
directly binds to the p21 promoter. 
2. To study the ligand-dependent co-factor associations of VDR and PPARβ/δ ex vivo. 
3. To assess the role of HDACs in the response of CDKI genes to 1α,25(OH)2D3. 
4. To build a dynamic model of the response of p21 to 1α,25(OH)2D3 with special emphasis 
on chromatin modifications and looping. 
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4. Materials and Methods 
This section provides the materials and methods for the parts of the research contained with the 
presented research articles that I have conducted myself. This also applies for the section with 
results, except for the in silico characterization of REs, performed by Dr. Christian Frank, and the 
execution of gel shift and reporter gene assays, performed by Prof. Carsten Carlberg. 
4.1 Materials 
4.1.1 Cell culture 
MCF-7 is a human luminal mammary cancer cell line derived from pleural effusion of a 69-year 
old woman with invasive ductal carcinoma (Neve et al., 2006). MCF-7 cells are responsive to 
estrogen and express wild-type p53, although at a lower level than normal breast epithelium 
(Neve et al., 2006; Raman et al., 2000). MDA-MB453 mammary luminal metastatic 
adenocarcinoma cells were derived from a pericardial effusion of a 48-year woman with breast 
cancer that had metastasized to the lymph nodes, brain and both pleural and pericardial cavities 
(Neve et al., 2006). MDA-MB453 cells do not express ERs and have mutated p53 protein with 
aberrations in the DBD (Lacroix et al., 2006; Neve et al., 2006). MCF-12A is a spontaneously 
immortalized mammary epithelial non-tumorigenic epithelial cell line established from residual 
tissue samples resulting from a reduction mammoplasty from a 60-year old woman with 
fibrocystic breast disease containing focal areas of intraductal hyperplasia (Neve et al., 2006). 
This cell line expresses wild-type p53, but lacks ERs and unlike MCF-7 and MDA-MB453 cells, 
shows basal lineage-like gene expression patterns instead of luminal (Neve et al., 2006). The 
HEK293 cell line was generated by transformation of normal human embryonic kidney cells with 
adenoviral DNA (Graham et al., 1977). 
MCF-7 cells were used in experiments for (I) and (III), MDA-MB453 cells for (III) and (IV), 
MCF-12A cells for (III) and HEK293 cells for (II). MCF-7 and MDA-MB453 cells were grown 
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in α-MEM containing 5 or 10 % fetal bovine serum (FBS), respectively, HEK293 cells in 
DMEM with 10 % FBS and MCF-12A cells were grown in a mixture of DMEM and Ham’s F12 
medium (1:1) with 20 ng/ml of epidermal growth factor, 100 ng/ml of cholera toxin, 10 mg/ml 
insulin, 500 ng/ml hydrocortisone and 5 % horse serum. All cell lines were grown in a humidified 
incubator (atmosphere 95 % air / 5 % CO2) and media was supplemented with 2 mM L-
glutamine, 0.1 mg/ml of streptomycin and 100 U/ml of penicillin. For experiments, phenol red-
free DMEM with 5 % charcoal-treated FBS and antibiotics was used, except for MCF-12A cells, 
for which above mentioned culture medium was used but supplemented with 5 % charcoal-
treated FBS instead of horse serum. For real-time PCR, ChIP and chromosome conformation 
capture (3C) assays cells were grown overnight prior to treatments. In siRNA experiments, 
DMEM supplemented only with only glutamine was used. 
4.1.2 Ligands 
In cellular experiments, the physiologically active ligand of VDR, 1α,25(OH)2D3, was used at a 
final concentration of 10 nM, diluted in ethanol (I, III) or in ethanol and DMEM (IV) (with either 
0.1 % or 0.001 % of solvent in cell culture medium, respectively). The hormone was kindly 
provided by Dr. Lise Binderup (LEO Pharma, Ballerup, Denmark) (I and III) or by Dr. Milan 
Uskokovic (BioXell Inc., Nutley, NJ, USA) (IV). The thymidylate synthase inhibitor 5-
fluorouracil (5-FU), that induces p53 protein levels, was used at 5 mM concentration diluted in 
dimethyl sulfoxide (DMSO) with 0.1 % of solvent in cell culture medium, and was purchased 
from Sigma-Aldrich (St. Louis, MO, USA) (I). The specific PPARβ/δ agonist GW501516 was 
purchased from Alexis Biochemicals (San Diego, CA, USA) and used at a final concentration of 
100 nM diluted in DMSO with 0.1 % of solvent in cell culture medium (II). The HDAC inhibitor 
trichostatin A (TSA) (Sigma Aldrich, St. Louis, MO, USA) was used in a concentration of 15 
nM, diluted in ethanol with 0.1 % of solvent in cell culture medium (III). 
4.1.3 DNA constructs 
The locations and sequences of the human p21 gene promoter fragments are provided in the 
original articles (I) and (III). The fragments were generated by PCR from human genomic DNA 
and sub-cloned into a plasmid containing the thymidine kinase minimal promoter and the 
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luciferase reporter gene (pGL3) with XbaI restriction enzyme (I, III) or into a plasmid (pGL4.10, 
Promega, Madison, WI, USA) that contains only the luciferase reporter gene with expression 
vector using XbaI and NheI restriction enzymes (IV). Point mutations to selected constructs were 
generated using the QuickChange site-directed mutagenesis kit (Stratagene) according to the 
manufacturer’s instructions. The locations of the mutations are indicated in the original 
publication (I). All constructs were verified by sequencing. For 3C experiments in (III) and (IV), 
positive controls were made from plasmids containing p21 promoter fragments as mentioned (III 
and IV). 1 µg of plasmid covering the responsive target region and 1 µg of plasmid covering the 
TSS were digested with 50 U of MvaI, Hpy8I or SchI (Fermentas, Vilnius, Lithuania) overnight at 
37 °C and ligated with T4 ligase (Fermentas) for 2 h at room temperature (RT).  
4.2 Methods 
4.2.1 In vitro methods  
4.2.1.1 siRNA interference 
Before siRNA transfection for (III), cells were grown to 30-40 % confluency in 6-well plates. 
Cells were the transfected with 200 pmol of each double-stranded siRNA oligonucleotides 
(Eurogentec, Liege, Belgium) with 5 µl of Lipofectamine 2000 (used for MCF-12A cells) or 
Lipofectamine RNAiMAX (MCF-7 and MDA-MB453) (Invitrogen, Carlsbad, CA, USA). The 
transfection reagent was diluted to DMEM supplemented only with glutamine and incubated for 
5 min at RT, during which time the oligonucleotides for each target were mixed and diluted to 
medium. Following this, the reagent and oligonucleotide mixture was mixed, followed by 20 min 
incubation at RT, after which the lipofectamin-oligonucleotide mixture was pipeted on medium-
aspirated cells. After 4 to 6 h from transfection, medium with charcoal-treated 5 % FCS was 
added to final volume of 2 ml. RNA extraction was performed 48 h after the start of the 
transfection. 
For (IV) MDA-MB453 cells were reverse transfected with Lipofectamine RNAiMAX 
(Invitrogen) with the aforementioned double-stranded siRNA oligonucleotides. In reverse 
transfection, the oligonucleotides were first diluted to medium, into which the transfection 
reagent was subsequently added and the mixture was incubated for 15 min at RT, followed by 
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addition of cells in medium. For RNA extractions 650,000 cells, for 3C assays 750,000 cells and 
for ChIP assays 4,500,000 cells were used. Cell treatments were started 24 h after plating, after 
which cells were used for RNA extraction, ChIP assays or 3C assays. 
4.2.2 Ex vivo analyses 
4.2.2.1 RNA extraction 
Cells were seeded on 6-well plates and grown overnight to reach 50 to 60 % confluency (I, III) 
or, for (IV) 650,000 cells for each well were seeded approximately 24 h prior to collection. Total 
RNA was extracted using the Mini RNA Isolation II kit (Zymo Research, HiSS Diagnostics, 
Freiburg, Germany). Prior to collection, cells were treated as indicated in the publications and 
washed twice (I, III) or once (IV) with ice-cold phosphate buffered saline (PBS, 140 mM NaCl, 
2.7 mM KCl, 1.5 mM KH2PO4, 8.1 mM Na2HPO4.2H2O), after which cells were lysed and RNA 
was extracted using 600 µl of ZR buffer. The RNA lysate was collected and adsorbed to matrix 
of the ZYMO Spin Columns and washed twice with RNA wash buffer (350 µl each time) with 1 
min of 14,000 x g centrifugation and discarding of the flow-through after each step. RNA was 
eluted to 50 µl of sterile H2O and the purity and RNA concentration was measured by a 
NanoDrop ND-1000 (NanoDrop, USA). 
4.2.2.2 cDNA synthesis 
To reverse-transcribe 1 µg of total RNA to cDNA in (I) and (III), 100 pmol of oligodT18 primer, 
20 nmol of dNTPs, 200 pmol of DTT, reverse transcriptase buffer (50 mM Tris–HCl, pH 8.3, 50 
mM KCl, 4 mM MgCl2, 10 mM DTT), 40 U of reverse transcriptase and 40 U of RNAse 
Inhibitor (buffer and enzymes from Fermentas) were incubated for 1 h at 37 °C in a 40 µl final 
volume. Following synthesis the reverse transcriptase was inactivated for 5 min at 95 °C and 
cDNA was diluted 1:10 in sterile H2O before further use. 
For (IV) cDNA synthesis was performed using Transcriptor first strand cDNA synthesis kit 
(Roche Diagnostics, Mannheim, Germany). Here, 1 µg of total RNA was pre-incubated with 50 
pmol of anchored oligodT18 (targeting the 5’ end of the 3’ poly(A) tail) for 10 min at 65 °C in 
volume of 13 µl and the subsequent synthesis was performed for 30 min at 55 °C with dNTP mix 
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(20 nmol of each), Transcriptor Reverse Transcriptase Reaction Buffer, 10 U of reverse 
transcriptase and 20 U of RNAse Inhibitor in 20 µl total volume. Following synthesis, the reverse 
transcriptase was inactivated for 5 min at 85 °C and the cDNA was diluted 1:20 with sterile H2O. 
4.2.2.3 Real-time PCR 
Real-time quantitative PCR (for I and III) was performed in an IQ-cycler (BioRad, Hercules, CA, 
USA) using the dye SybrGreen I (Molecular Probes, Leiden, The Netherlands) that binds to 
double stranded DNA. Per reaction, 1 U Hot Start Taq polymerase (Fermentas) (I) or FastStart 
polymerase (Roche) (III), 0.18 mM of MgCl2, 1 x HotStart or FastStart buffer, respectively, 
dNTPs (0.2 mM of each), 1:2000 diluted SybrGreen stock and 2 % DMSO was used in a total 
volume of 20 µl. In the PCR, DNA was pre-denaturated at for 5 min 95 °C, amplified with 40 
cycles of 30 s of denaturation at 95 °C, 30 s of primer annealing at primer specific temperatures 
and 30 s of elongation at 72 °C, followed by further elongation of 10 min at 72 °C.  
In (IV), the real-time quantitative PCR for cDNA was performed using a LightCycler® 480 
System (Roche) and FastStart SYBR Green Master mix (Roche). Each reaction was performed 
using 4 pmol of each specific primer, 4 µl of cDNA template and 1x supermix in a volume of 10 
µl and the PCR cycling conditions were: pre-incubation for 10 min at 95 °C, 38 cycles of 20 s at 
95 °C, 15 s at 60 °C and 15 s at 72°C. 
Fold inductions were calculated using the formula 2(ΔΔCt), where ΔΔCt is the ΔCt(stimulus)-
ΔCt(solvent), ΔCt is Ct(target gene)-Ct(RPLP0), Ct is the cycle at which the threshold is crossed 
and RPLP0 is the housekeeping gene ribosomal protein, large, P0. Quality of the PCR product 
was monitored using post-PCR melt curve analysis. 
4.2.2.4 Chromatin immuno-precipitation assay 
Nuclear proteins were cross-linked to genomic DNA by adding formaldehyde directly to the 
medium to a final concentration of 1 % with 10 (I) or 5 min (II-IV) incubation at RT. Cross-
linking was stopped by adding glycine to a final concentration of 0.125 M and incubating for 5 
min at RT on a rocking platform. The medium was removed and the cells were washed twice 
with ice-cold PBS. The cells were collected by scraping into ice-cold PBS supplemented with a 
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protease inhibitor cocktail (Roche) (I) or into plain ice-cold PBS (II-IV). Cells were pelleted by 
centrifugation (700 g for 5 min at 4 °C), pellets were resuspended in lysis buffer (1 % SDS, 10 
mM EDTA, protease inhibitors and 50 mM Tris-HCl, pH 8.1) and the lysates were sonicated to 
result in the majority of DNA fragments being 300 to 1000 bp in length. 
Cellular debris was removed by centrifugation (16,000 g for 15 min at 4 °C), 1:40 volume of the 
supernatant was taken for inputs that serve as a control for the target DNA amount for each 
sample. For outputs, the remaining supernatant was diluted 1:10 in ChIP dilution buffer (0.01 % 
SDS, 1.1 % Triton X-100, 1.2 mM EDTA, 16.7 mM NaCl, protease inhibitors and 16.7 mM 
Tris–HCl, pH 8.1). The input sample was diluted in ChIP Dilution buffer and further processed 
like outputs from step with reverse-crosslinking onwards. Non-specific background was removed 
by incubating the chromatin resuspension with a salmon sperm DNA/protein A agarose slurry 
(Upstate Biotechnology, Lake Placid, NY, USA) for 30 min at 4 °C with agitation (I, III). 
Addition of 2.4 µg of salmon sperm DNA directly to the samples or pre-incubation with salmon 
sperm beads was left out and instead protein A agarose bead slurry (Upstate) was blocked 
overnight with 10 mg/ml of bovine serum albumin and 0.1 mg/ml of salmon sperm DNA at 4 °C 
(IV). The samples were centrifuged (I-III) and the recovered chromatin solutions were incubated 
with 1 µg of purified antibodies or with 1.8 µl of anti-sera, both indicated in individual 
publications, overnight at 4 °C with rotation. 
The immuno-complexes were collected with 60 µl of protein A agarose slurry for 2 h (I) or 1 h 
(II-IV) at 4 °C with rotation. The beads were pelleted by centrifugation for 1 min at RT at 100 g 
and washed sequentially (each time for 5 min) by rotation with 1 ml of the following buffers: low 
salt wash buffer (0.1 % SDS, 1 % Triton X-100, 2 mM EDTA, 150 mM NaCl and 20 mM Tris–
HCl, pH 8.1) (used twice in IV), high salt wash buffer (0.1 % SDS, 1 % Triton X-100, 2 mM 
EDTA, 500 mM NaCl and 20 mM Tris–HCl, pH 8.1) and LiCl wash buffer (0.25 mM LiCl, 1 % 
Nonidet P-40, 1 % sodium deoxycholate, 1 mM EDTA and 10 mM Tris–HCl, pH 8.1). Finally, 
the beads were washed twice with 1 ml TE buffer (1 mM EDTA and 10 mM Tris–HCl, pH 8.0) 
and then eluted twice with 250 µl of elution buffer (1 % SDS and 100 mM NaHCO3) by 
incubation for 15 min at RT with rotation. For (IV) chromatin bound to agarose beads was eluted 
with a different elution buffer (25 mM Tris-HCl pH 7.5, 10 mM EDTA, 0.5 % SDS) for 30 min 
at 65 °C followed by second elution for 2 min at RT. 
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After centrifugation, the supernatants were collected and combined, and the cross-linking was 
reversed by adding NaCl to final concentration of 200 mM (I) and incubating overnight at 65 °C. 
The remaining proteins were digested by proteinase K either following reverse crosslinking (I) by 
incubation for 1 h at 45 °C with proteinase K from Invitrogen (Carlsbad, CA, USA; final 
concentration 40 µg/ml) or by proteinase K from Fermentas (Vilnius, Lithuania; final 
concentration 38 µg/ml) during the reverse crosslinking at 65 °C (II-IV). The DNA was 
recovered by phenol/chloroform/isoamyl alcohol (25/24/1) extraction and precipitated with 0.1 
volumes of 3 M sodium acetate (pH 5.2) and 2 volumes of ethanol using glycogen as a carrier. 
Input and output samples were dissolved in 200 µl and 60 µl of H2O, respectively. The difference 
in dilution volumes, in addition to the difference in the amount of starting material used were 
taken into account when calculating PCR results from ChIP template. 
For re-ChIP (I-III) the immuno-complexes were eluted by adding 100 µl re-ChIP elution buffer 
(10 mM DTT) for 30 min at RT with rotation, the supernatant was diluted 1:40 in ChIP dilution 
buffer and the antibody against the second protein of interest was added, the new immuno-
complexes were allowed to form by incubating overnight at 4 °C on a rocking platform, the 
immuno-complexes were collected by incubating with 120 ml protein A agarose slurry for 2 h at 
4 °C on a rocking platform and finally washed as indicated above. Elution and DNA purification 
were then carried as described above for regular ChIP. 
4.2.2.5 Chromatin conformation capture assay 
In 3C assays, chromatin is crosslinked in living cells as in ChIP assays, but instead of shearing 
and antibody-based selection, chromatin is restricted and then ligated in circumstances favoring 
intramolecular interactions. Hence the probability that two distant chromatin regions separated by 
multiple restriction sites will form a ligation product increases, if they are looped together. To 
exclude the contribution of random chromatin associations, we used non-responsive regions 
between the TSS and the responsive regions as negative controls as the probability of random 
interactions increases with decreasing distance (Simonis et al., 2007). For (III) 1:10 of chromatin 
in a 60 to 70 % confluent cell culture flask (175 cm2) or for (IV), chromatin from two wells of a 
6-well plate (750,000 cells plated per well), was collected, crosslinked and lysed as for ChIP 
assays, except for the sonication time, which was reduced to two (III) or one (IV) 15 s pulse to 
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complete cell lysis without shearing the DNA. After removal of cellular debris by centrifugation, 
100 (III) or 25 μl of chromatin was diluted in 345 μl (III) or 75 μl (IV) of ChIP dilution buffer 
and digested overnight at 37 °C with the restriction enzymes MvaI (50 U for (III), 25 U for (IV)), 
Hpy8I (25 U) or SchI (25 U, only used in (III)) and Red buffer (with MvaI) or Tango buffer (with 
Hpy8I or SchI) (enzymes and buffers from Fermentas, Vilnius, Lithuania). Digested chromatin 
was diluted 1:1.5 (III) or 1:6 (IV) to T4 ligation buffer supplemented with 0.5 mM ATP and 
ligated with 50 (III) or 15 U (IV) of T4 DNA ligase (Fermentas, Vilnius, Lithuania) for 2 h at 16 
°C (III) or for 4 h at RT (IV). Samples were reverse crosslinked and DNA was recovered as 
described for ChIP assays. 
4.2.2.6 PCR of chromatin templates 
Semi-quantitative PCR for (I), (II) and (III) was performed in an IQ- and the dye SybrGreen I 
(stock diluted 1:2000) with 1 U Hot Start Taq polymerase (Fermentas) (I) or FastStart polymerase 
(Roche) (II, III), 0.09 mM MgCl2, 1 x HotStart or FastStart buffer, respectively, dNTPs (0.2 mM 
of each) and 2 % DMSO was used in a volume of 25 µl. PCR program used was the same as 
described for real-time PCR in section 4.2.3.3. The PCR products were separated by 
electrophoresis through 2 % agarose and shown as representive gels (I, II) or with strong protein 
association (I, III), relative enrichment levels were calculated using the formula 2-ΔCt, where ΔCt 
is Ct(output) - Ct(input) normalized by the amount of chromatin used for preparation of input 
versus output. Gel images were scanned on a FLA3000 reader (Fuji) using ScienceLab99 
software (Fuji). 
In (IV) genomic primers indicated in the original publication were designed for each of the three 
VDRE carrying regions and the TSS of the p21 gene and for their quantification 6-
carboxyfluorescein (FAM)-modified probes (Eurogentec, Liege, Belgium) were used. Similarly, 
primers were designed for the detection of 3C ligation products and their TaqMan quantification 
(Eurogentec, Liege, Belgium). To achieve quantifiable product specificity, the probes used for 3C 
ligation products were targeted against the ligation site, as described previously for quantification 
of chromatin looping (Jing 2008). Oligonucleotides were obtained from Eurogentec. Real-time 
quantitative PCR was performed with the Maxima Probe qPCR master mix (Fermentas), 4 µl of 
purified DNA template, 4 pmol primers and 1 pmol labeled probe on a LightCycler® 480 System 
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(Roche). The PCR cycling conditions for 2-step PCR used were: pre-incubation for 10 min at 95 
°C, 50 cycles of 20 s at 95 °C and 60 s at 60 °C. The PCR products were also resolved on 2 % 
agarose gels to control for correct product size. Relative association of chromatin bound proteins 
or histone modifications were calculated using the formula 2-ΔCt, where ΔCt is Ct(output)-
Ct(input), output is the immuno-precipitated DNA and input is the purified genomic DNA from 
starting material of the ChIP assay. For the 3C assay relative chromatin looping was calculated 
using the formula 2-ΔCt, where ΔCt is Ct(3C ligation product)-Ct(positive control plasmid) and 
then divided by the 2-ΔCt value of non-treated p21-2 for Hpy8I restricted template or p21-3 for 
MvaI restricted template. Positive control plasmids are described in original publications and in 
section 4.1.3. 
Anna Saramäki:  Regulation of the p21 (CDKN1A) gene at the chromatin level by 1α,25-(OH)2D3 
 
58 Kuopio Univ. Publ. C. Nat. and Environ. Sci. 246: 1-100 (2008) 
 
Kuopio Univ. Publ. C. Nat. and Environ. Sci. 246: 1-100 (2008) 59 
 
 
 
5. Results  
5.1 The human p21 gene is regulated by p53 and VDR via multiple response 
elements 
The p21 has been characterized as the main target gene of p53 in order to block the cell cycle 
upon exposure to cellular stresses, such as DNA damage, hypoxia or oncogene activation. The 
regulation of p21 expression by p53 occurs via two REs at positions 1400 and 2300 bp upstream 
from the p21 TSS, and the p53 response can be activated, e.g., by inducing translation of p53 
protein with the application of the cytotoxic anti-cancer drug 5-FU (Espinosa 2001, Ju 2007). 
1α,25(OH)2D3 has been suggested to up-regulate p21 gene transcription via a VDRE at position 
750 bp upstream of the TSS, but the functionality of this RE has been questioned, as well as the 
role of p21 as a primary 1α,25(OH)2D3 target gene (Liu et al., 1996b; Danielsson et al., 1997; 
Verlinden et al., 1998). Most established REs on the p21 promoter have been characterized based 
on mutation/deletion analysis of promoter constructs with a length of 2.5 kbp or less, thus 
ignoring putative distal REs. Additionally, the transcriptional response is often measured only in 
one or two time points neglecting the possible dynamic nature of the response. 
To assess the transcriptional response of the p21 gene to 1α,25(OH)2D3 or to induce p53 in MCF-
7 breast cancer cells, the cells were treated with 1α,25(OH)2D3 or 5-FU, respectively, or solvent 
and used as a template for real-time PCR and ChIP assays. The induction of p53 by 5-FU caused 
a steady increase of p21 mRNA up to a level of 5.2-fold after 360 min of stimulation, whereas 
1α,25(OH)2D3 induced p21 mRNA expression with a maximum of only 1.6-fold induction after 
120 min of stimulation (I, Figs. 1A and B).  
In order to get an extensive view of binding of VDR and p53 on the p21 promoter, we screened 
7.1 kbp of chromosomal DNA upstream of the TSS by overlapping ChIP regions. In addition to 
the two established p53 binding sites, we discovered a novel but relatively weak site residing 4 to 
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4.5 kbp upstream of the TSS, as well as (indirect) binding onto the TSS, with between 3.7- to 70-
fold inductions by 5-FU (I, Figs. 2B and C). Surprisingly, VDR was found to associate with two 
regions with p53 binding sites, residing at -2 to -2.5 kbp and the newly identified p53 RE at 4 to 
4.5 kbp upstream the TSS (I, Fig. 3). In addition, VDR was binding to a region 6.7 to 7.1 kbp 
upstream of the TSS, but not to the region with the previously described VDRE at position -750 
bp. In in silico screening for VDR and p53 binding sites on the p21 promoter regions that were 
positive in ChIP assays, eight and five putative REs were found (I, Fig. 4), of which five and 
three were found positive in in vitro gel shift assay, respectively. The functionality of putative 
REs was confirmed by reporter gene assays, where both the previously established p53 binding 
sites and the novel p53 site as well as the five newly identified VDREs residing on three ChIP 
regions were confirmed to be functional in activation of transcription. 
In conclusion, these data confirm p21 as primary 1α,25(OH)2D3 target gene with three functional 
responsive regions that bind VDR both in vitro and ex vivo, residing at 2, 4.5 and 7 kbp upstream 
of the TSS. The two proximal 1α,25(OH)2D3 target regions also harvest functional p53 REs, 
putatively representing regulatory hotspots on the human p21 gene promoter. 
 
5.2 Association of nuclear receptor complexes on regulatory regions of the 
human PDK gene family and the human p21 gene 
As NRs, the PPARs and VDR have similarities in their strategy to induce target gene expression: 
they share a common heterodimerization partner RXRα, bridge to the basal transcription 
machinery and to Pol II via the MED1 subunit of the Mediator complex (Rachez et al., 1999; Zhu 
et al., 1997) and associate with a multitude of shared co-factors (Mukherjee et al., 2002; Deeb et 
al., 2007; Feige and Auwerx, 2007). On the other hand, PPARs possess intrinsic, ligand-
independent ability to associate with CoAs thus resembling orphan NRs, whereas VDR is able to 
recruit CoAs only in the presence of its ligand (Molnar et al., 2005). 
In HEK293 cells treated with the selective PPARβ/δ agonist GW501516, the association of 
PPARβ/δ with co-factors and phosphorylated Pol II (p-Pol II) was studied on the TSSs and on six 
responsive regions containing functional PPAR REs (PPREs) of the genes pyruvate 
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dehydrogenase kinase (PDK) 1 to 4 by re-ChIP assays (II, Fig. 5). Of the regions studied, six 
showed p-Pol II enrichment suggesting their direct transcriptional contribution. This association 
was also ligand-dependent, except for the region 2 of PDK4. The association with RXRα was 
more divergent in response to ligand and even repressed by the ligand on region 2/TSS and on 
region 3 of the PDK2 and PDK3 genes, respectively. Association of the CoA PGC-1α was 
induced except for the TSSs of PDK 2 and 4 genes, whereas MED1 (TRAP220 in Fig. 5 of II) 
association was reduced by the ligand on the PDK2 gene TSS/region 2 and on the PDK3 gene 
region 1. The ligand-free association with MED1 may reflect the aforementioned ability of 
PPARs to associate with CoAs in the apo-form. 
Composition of NR complexes by re-ChIP was also studied in MDA-MB453 (III) and MCF-7 (I) 
breast cancer cells targeting VDR-associated factors on the TSSs of all expressed CDKI genes 
(III, Fig. 2D) and the 1α,25(OH)2D3-responsive regions of p21 (I, Fig. 7; III, Fig. 3E). Although 
both p18 and p21 TSSs harvested VDR-Pol II complexes, they were not induced with 60 min of 
ligand treatment (III, Fig. 2D), unlike seen for the responsive regions (III, Fig. 3E). In contrast to 
the PPAR response of the PDK genes, MED1 association with VDR was not present on the 
1α,25(OH)2D3-responsive regions of the p21 gene without ligand, supporting the low CoA 
binding ability of non-liganded VDR (Molnar 2005). Also, VDR associated with CBP and 
especially with NCOA1 (referred as SRC-1 in I) in MCF-7 cells in treatment-time dependent 
manner starting from 15 to 30 min of treatment (I, Fig. 7). CBP showed pronounced basal 
association on regions that harvest also p53, presumably due to the ability of CBP to associate 
with p53 in addition to NRs (Lill 1997, Avantaggiati 1997). 
In conclusion, both PPARβ/δ and VDR form complexes with Pol II and MED1 on responsive 
regions of their target genes, where VDR is dependent on the presence of its ligand and PPARβ/δ 
shows higher basal ability to induce bridging via MED1. 
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5.3 Role of HDACs in regulation of human CDKI genes by 1α ,25(OH)2D3 and 
TSA in mammary cell lines 
In addition to mutations in DNA sequence, chromatin alterations leading to aberrant gene 
expression patterns are crucial in both onset and progression of cancer (Baylin and Ohm, 2006). 
The reversal of aberrant histone modifications and hence, the following aberrant gene expression 
patterns in cancer cells motivates the research on HDAC inhibitors, which have been shown to 
possess potent anti-cancer activities in pre-clinical studies (Bolden et al., 2006). Among the anti-
proliferative targets of HDAC inhibitors are several members of the CDKI family, namely p15 
(CDKN2B), p16 (CDKN2A), p18 (CDKN2C), p19 (CDKN2D) and p21 (CDKN1A) (Richon et al., 
1996; Hitomi et al., 2003; Yokota et al., 2004a; Yokota et al., 2004b; Wu et al., 2008). ). As 
several of the CDKI genes have been shown to respond to 1α,25(OH)2D3 as well (Liu et al., 
1996b), we wanted to explore the modulation of this response by the HDAC inhibitor TSA and 
the roles of individual HDACs in this response. 
The mRNA expression and TSS histone acetylation status of the four CDKI genes p18, p19, p21 
and p27 were monitored by real-time PCR (III, Figs. 2B and S2A) and ChIP assays (III, Figs. 2B 
and 3C) in three mammary cell lines with different stages of malignancy, MCF-12A, MCF-7 and 
MDA-MB453 cells, which were treated with either 10 nM 1α,25(OH)2D3, 15 nM TSA or their 
combination. The three remaining CDKI gene family members, p15, p16/p14 (both transcribed 
from CDKN2A) and p57 (CDKN2C) were not expressed to detectable level and hence were 
excluded from further analysis. The highest inductions were seen with TSA on the expression of 
p18 and p19 mRNA in MCF-7 cells (11- and 6-fold at 4 h) (III, Figs. 2B and S2B), accompanied 
by inductions in the acetylation levels of the TSSs regions as seen in ChIP assays with 1 h of 15 
nM TSA treatment (2-fold for H3K14ac, called AcH3K14 in III, and 4-fold for H4ac, called 
AcH4 in III, in MCF-7 cells; III, Fig. 2A). However, the TSS induction of the acetylation at 1 h 
cannot explain the high mRNA inductions, since the acetylation was similarly induced on the 
p18-TSS in MDA-MB453 cells and on the p21-TSS in MCF-7 cells, in neither of which the 
change was transmitted to high transcript levels. 
In all three cell lines the established 1α,25(OH)2D3 target gene p21 (Liu et al., 1996b) was 
significantly induced by 1α,25(OH)2D3 (1.6- to 3.6-fold). Additionally, the other studied genes 
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showed inductions, but less consistently. However, in most cases these mRNA fold inductions 
were not reflected by changes of the acetylation levels of the respective CDKI gene TSS regions 
(III, Fig. 2A), unlike on the 1α,25(OH)2D3-responsive regions of p21, namely p21-1 (p21-7 in 
(I)), p21-2 (p21-12C in (I)) and p21-3 (p21-19 in (I)) (see Fig. 3A of (III) for location). On the 
ligand-responsive regions, the effects of 1α,25(OH)2D3 on the acetylation status were more 
pronounced than seen on the TSS (III, Fig. 3C), while TSA still induced both of the studied 
modifications. In general, the combined treatment with TSA and 1α,25(OH)2D3 resulted in all 
three cell lines in a higher mRNA expression level than either of the substances alone (an 
exception was the p27 gene in MCF-7 cells, see Fig. 2B and S2B of III), but not in additional 
histone acetylation on the TSSs (III, Fig. 2A). In a number of cases, these co-operative effects 
were also statistically significant, pointing out the potential of combined use in the attenuation of 
proliferation (III, Fig. S2B). On one responsive region, p21-2 at -4.5 kbp from the TSS, the 
combination of the ligand and TSA even synergistically induced H3K14ac on in MDA-MB453 
cells (III, Fig. 3C).  
To elucidate the role of individual HDACs on acetylation changes on the regulatory regions of 
CDKI genes, we analyzed, by ChIP assays, the occupancy of the HDAC1 to 7 and NCoR1 on the 
CDKI gene TSSs and the 1α,25(OH)2D3-responsive regions of the p21 gene (III, Figs. 2C and 
3D). HDAC3 was the most pre-dominant deacetylase on the TSSs except for p27-TSS (III, Fig, 
2C), which was also inert to induction of acetylation by TSA (III, Fig. 2A). HDAC3 was only 
associated on ligand-responsive regions, which also bind p53 (I, Fig. 2B) and only in p53 positive 
cell lines. NCoR1 was also widely present at the TSSs and to lesser extent on ligand-responsive 
regions of the p21 gene. HDAC5 was enriched especially on the TSSs of the Cip/Kip subfamily 
genes p21 and p27 and to ligand-responsive regions of p21. HDACs 6 and 7 showed less 
enrichment, while the binding of HDACs 1 and 2 was highly infrequent and the latter were not 
binding to responsive regions at all. In conclusion, the HDAC association pattern on the 
1α,25(OH)2D3-responsive regions of the p21 gene differed clearly from that of the CDKI TSS 
regions, with less overall HDAC occupancy, lower HDAC3 enrichment and more dominant 
HDAC4 and HDAC5 (III, Fig. 3D). 
The effect of 1 h treatment with either TSA, 1α,25(OH)2D3 or their combination on the VDR-
HDAC or VDR-NCoR1 complexes were elucidated by re-ChIP assays (III, Figs. 2D and 3E), in 
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which HDAC3 to 7 were chosen based on their occupancy on the studied regions and MDA-
MB453 cell line to see p53-independent patterns. HDAC4, 6 and 7 showed most consistent co-
occupancy with VDR on all p21 regions, with reduction upon ligand, whereas HDAC3 showed 
lower and more fragmented basal enrichment and was even induced by the ligand. HDAC5 was 
strongly co-immuno-precipitating with VDR only to the p21-TSS and responded only to TSA, 
showing no change with 1α,25(OH)2D3. The p18-TSS also showed ligand-dependent VDR-
HDAC complex enrichment accompanied by a mild mRNA fold induction (III, Figs. 2B and D).  
The putative direct contact between the 1α,25(OH)2D3-responsive regions and the TSS of p21 
was studied by 3C assays, in which 1α,25(OH)2D3, but not TSA, induced looping of the two more 
distal regions at positions -4.5 kbp and -6.9 kbp (III, Fig. 3B). Surprisingly, DNA looping could 
not be detected from the more proximal region at position -2.3 kbp to the TSS, although ligand 
was able to induce both histone acetylation and VDR–Pol II complex formation on this region 
(III, Figs. 3B, C and E). 
In order to define the contribution of selected HDACs to both basal expression and response to 
1α,25(OH)2D3 and/or TSA, the three mammary cell lines were transfected with siRNAs against 
VDR, NCoR1 or HDAC3, 4, 6 or 7 (III, Figs. 3A, 3B, S4A and B). The effects of the siRNA-
treatments to the ligand-responsiveness of the highly 1α,25(OH)2D3 inducible CYP24A1 gene in 
MCF-7 cells (III, Fig. S3C) was also assayed to see how general the contributions of HDACs in 
ligand response to the ligand are. HDAC5 was left out based on the low occupancy on VDR 
complexes on the ligand-responsive regions. Effects of siRNA on response to treatments in MCF-
12A cells were hardly significant and are not addressed here. Inhibition of expression of HDAC6 
or 4 broadly induced the basal expression of CDKI genes, while HDAC6 siRNA did not inflict 
the effects of the treatments. Knockdown of HDAC4 attenuated the high induction of p18 to TSA, 
but further induced the response of the CYP24A1 gene to 1α,25(OH)2D3 in MCF-7 cells. Release 
from HDAC3 repression strongly and specifically induced the basal expression of the INK4 sub-
family genes p19 and especially p18, and also attenuated the induction of these genes by TSA. In 
addition to the inhibition of HDAC4, siRNA against HDAC3 and 7 also increased the observed 
fold induction of the CYP24A1 gene as well as the p21 gene by 1α,25(OH)2D3 in MCF-7 cells. 
NCoR1, and surprisingly, un-liganded VDR, repress CDKI genes, as their removal induced a 
significant rise in CDKI basal expression. Knockdown of VDR or NCoR1 also intensified the 
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response of p18 and partly p19 to TSA and attenuated the response of the p21 gene to 
1α,25(OH)2D3, whereas of the proteins studied, only VDR seemed to be needed for the ligand 
response of the CYP24A1 gene. Overall, HDACs attenuate CDKI gene expression and response 
to 1α,25(OH)2D3, and combining an HDAC inhibitor with 1α,25(OH)2D3 treatment provides 
means of augmenting the effect of the ligand via increased induction of CDKI genes. 
 
5.4 The cyclical response of human p21 gene to 1α ,25(OH)2D3 at the level of 
transcription factor binding, chromatin looping and transcription 
In a classical model of NR activation, the ligand acts as an on-off switch of transcription as it 
leads to displacement of CoRs and recruitment of co-factors to the receptor, which in turn leads 
to active transcription of the target gene (Deeb et al., 2007). Recently, models have been 
presented for the activation of transcription by NRs, where ligand-dependent transcription is seen 
as a cyclical process with alternating activating and repressive actions on chromatin, as proposed 
for ERα on the trefoil factor-1 gene (Metivier et al., 2003). 
To assay the dynamics of the p21 induction, real-time quantitative PCR analysis of p21 mRNA 
expression in response to 1α,25(OH)2D3 was performed in a detailed time course of 300 min with 
15 min intervals on un-synchronized MDA-MB453 cells (IV, Fig. 1). In the early phase, the 
accumulation of p21 mRNA peaked first at 60 min and at 105 min resulting in significant but low 
(20 to 30 %) increase in transcript levels. At 150 min of 1α,25(OH)2D3 treatment time, p21 
mRNA peaked to 1.7-fold when compared to vehicle, followed by a decrease in transcript level 
close to that of untreated cells within 45 min. Subsequently, a fourth peak appeared at 210 min 
and a fifth peak at 255 to 270 min. After each of these peaks, the accumulation of p21 mRNA 
ceased resulting in a decrease of p21 mRNA levels. The peaks of p21 steady state mRNA levels 
appeared in cycles of 45 to 60 min with the longest lag-time after the major peak at 150 min. 
These data indicate that 1α,25(OH)2D3 induces the transcription of the p21 gene only for 
repeated, short periods at selected time points, and that between these time points transcription is 
actively restricted. 
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In order to elucidate the events on chromatin that precede and putatively lead to cyclical mRNA 
accumulation, we performed quantitative ChIP assays using FAM-labeled real-time PCR probes. 
We assessed the enrichment of VDR, serine 5 phosphorylated Pol II, MED1, HDAC3, HDAC4, 
CBP, NCoR1, YY1, the lysine demethylase LSD1 as well as activity-linked histone 
modifications H3K4me2 and H3K9ac on the p21 TSS and the three 1α,25(OH)2D3-responsive 
regions p21-1, -2 and 3, targeting the initial phase of transcription from 0 to 150 min with 15 to 
30 min intervals (IV, Figs. 2A-C). The chromatin response of the p21 gene to 1α,25(OH)2D3 
begun with an initial rise in MED1 association on both 1α,25(OH)2D3-responsive regions and 
TSS, LSD1 induction on TSS and release of HDAC3 from the responsive regions. This was 
followed by induction of H3K9ac and H3K4me2 on both distal enhancers and on the TSS, 
leading to increased p-Pol II association on both the TSS and REs and VDR association on the 
REs. The peak in CBP, H3K4me2 and H3K9ac on the TSS at 30 min was followed by a drastic 
decrease in association of histone modifications, and putatively of nucleosomes, at 45 to 60 min 
preceding the initial peak in mRNA accumulation.  
At 90 min binding of VDR to responsive regions was enhanced with re-association of MED1 and 
p-Pol II and a peak in H3K9ac, preceding the second mRNA accumulation peak at 105 min. 
Subsequently there was an increase in CBP, H3K4me2 and H3K9ac on the TSS, after which, at 
150 min, VDR, p-Pol and MED1 were enriched on 1α,25(OH)2D3-responsive regions, with a 
time point which displayed increased p21 mRNA accumulation. Basal repression of the REs by 
HDAC3, NCoR1 and YY1 on the p21-1 and p21-3 regions was decreased by ligand treatment 
within 15 to 30 min, but was re-initiated at 120 min and on responsive regions, even induced 
when compared to non-treated cells to decrease activating histone modifications and hence 
diminish transcription after it has peaked. In short, these results show distinct cyclicity in 
especially VDR, p-Pol II and MED1 associations as well as suggest a clearance of histone 
modifications from the TSS upon transcription initiation. 
To unravel the spatial prerequisites as to how the 1α,25(OH)2D3-responsive regions, up to 7 kbp 
away from the TSS dynamically harvest p-Pol II and hence contribute to enhanced p21 gene 
transcription, we performed 3C assays. As for ChIP, we used FAM-labeled real-time PCR probes 
to gain maximum specificity of the ligation products. Association of two most proximal 
1α,25(OH)2D3-responsive regions to the TSS was studied using the restriction enzyme Hpy8I, 
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whereas for most distal region p21-3, MvaI was used as Hpy8I has a target sequence between the 
two VDREs on this region (IV, Fig. 3A). For 3C assays MDA-MB453 cells were treated 
identically as for ChIP assays. On the basal state both the p21-1 and p21-3 regions looped to the 
TSS, suggesting a role for these regions in repression by un-liganded VDR, as these regions also 
harvested NCoR1 and HDAC3 without the ligand (IV, Figs. 3B and 2B). The increase seen in 
MED1 association at 15 to 30 min (IV, Fig. 2B) did not manifest significantly on the association 
of ligand-responsive regions to the TSS, although the first peak on chromatin association 
appeared from p21-2 to the TSS after 30 min of treatment. On 1α,25(OH)2D3-responsive regions 
chromatin looping to the TSS was the highest after 90 min of treatment, with 2- to 15-fold 
induction when compared to non-treated cells. This induction of looping from 1α,25(OH)2D3-
responsive regions to the TSS was concomitant to p-Pol II enrichment on these regions, thus 
explaining its presence on regions up to 7 kbp away from the TSS. In conclusion, basal looping 
from 1α,25(OH)2D3-responsive regions to the TSS in non-treated cells is associated with 
enrichment of CoRs to the responsive regions. Introduction of ligand to the cells induces 
chromatin loops from all three 1α,25(OH)2D3-responsive regions of the p21 promoter to the TSS 
in a dynamic manner. Via looping they contribute to initiation of transcription cycles, which is 
supported by concomitant enrichment of p-Pol II on these regions. 
ChIP results implied an important role for MED1, CoRs and histone modifying enzymes in 
transcriptional response of the p21 gene to 1α,25(OH)2D3. In order to assess this, the expression 
of MED1, CBP, HDAC3, HDAC4, LSD1, NCoR1 or YY1 was diminished by siRNA. As 
expected, removal of MED1 completely abolished induction of p21 gene expression and 
transcription cycles, whereas removal of LSD1 decreased p21 basal expression and the peak at 
240 min was lost. Even though the knockdown of HDAC4 and HDAC3 both induced the p21 
basal expression, further induction and cycling of p21 expression was abolished by loss of 
HDAC4, whereas without HDAC3 the first induction at 150 min was abolished but the 
transcriptional cycling remained at later time points. Inhibition of either NCoR1 or YY1 caused 
an analogous change to the p21 transcript response showing lower inductions and deviated 
timing. Inhibition of CBP expression had no effect on transcription even though 1α,25(OH)2D3 
induced significant changes in CBP enrichment on all regions studied. This implies that CBP, 
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although present on the regulatory regions of p21, is not essential to response of p21 to 
1α,25(OH)2D3 and may be replaced by other histone acetylating CoAs. 
The drastic effects of removal of a Mediator complex subunit MED1, HDACs or the demethylase 
LSD1 on the 1α,25(OH)2D3 influenced cycling of p21 steady state transcript levels, suggest a 
crucial role of histone modifications in this phenomenon. Hence, we assayed the effect of 
removal of MED1, HDAC4 or LSD1 on acetylation of H3K9 or dimethylation of H3K4 by 
combined siRNA and ChIP assays (IV, Fig. 5). Surprisingly, inhibition of HDAC4 did not 
systematically induce basal H3K9 acetylation levels and even reduced this modification on two 
regions. The effects of siLSD1 were also mild on both modifications, even though LSD1 has the 
potential to remove H3K4me2 and indirectly induce H3K9ac by removing of the methyl group in 
the same residue. In spite of the low effects seen on the basal level, inhibition of either HDAC4 
or LSD1 inhibited the clearance of both H3K4me2 and H3K9ac from TSS region, suggesting an 
important role for these modifiers in removal of nucleosomes from TSS in preparation for 
transcription. On the ligand-responsive regions MED1 and HDAC4 were essential for the 
induction of H3K4 dimethylation on the proximal region p21-1, whereas on the most distal 
1α,25(OH)2D3-responsive region of the p21 promoter, p21-3, MED1, HDAC4 and LSD1 were 
similarly indispensable for induction of H3K9 acetylation. These results imply a strong interplay 
between H3K9ac and H3K4me2 as the removal of the demethylase inhibits the induction in 
acetylation and the removal of the deacetylase blocks the enhancement of dimethylation. 
As MED1, HDAC4 or LSD1 are crucial to ligand-dependent dynamical changes in histone 
modifications and resulting mRNA accumulation, a factor-specific siRNA transfection followed 
by a 3C assays were performed to study their role in chromatin looping (IV, Fig. 6). On the 
proximal region p21-1, 1α,25(OH)2D3 only mildly induced looping and the effects of above 
mentioned siRNAs on ligand-induced looping from p21-1 to the TSS were not significant, even 
though inhibition of LSD1 increased levels of association of this region to the TSS containing 
one. On the contrary, on the two distal elements removal of either MED1 or LSD1 blocked the 90 
min peak in association to the TSS, but did not effect the basal looping significantly. For the most 
distal region at -7 kbp, also HDAC4 was essential for looping. These results confirm that, as 
expected, bridging from VDR to the basal transcriptional machinery by MED1 is essential for the 
dynamic looping of the distal ligand-responsive regions of the p21 gene to its TSS. Significantly, 
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we found that also ordered and specific deacetylation by HDAC4 and demethylation by LSD1 are 
essential for optimal chromatin looping. 
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6. Discussion  
6.1 Human p21 is a primary 1α ,25(OH)2D3 target gene 
The hypothesis of p21 as a direct 1α,25(OH)2D3 transcriptional target has been repeatedly 
questioned but our studies present firm evidence to support it. First of all, we characterized three 
novel functional binding sites associated with VDR-Pol II complexes ex vivo in both of the 
studied mammary cancer cell lines used in this study (I, III). Secondly, we show coherent 
transcriptional response of p21 to 1α,25(OH)2D3 in three mammary cell lines with different 
stages of malignancy, and thirdly, we show ligand-dependent chromatin looping that provides a 
physical contact between 1α,25(OH)2D3-responsive regions and the p21 gene TSS. Induction of 
TGF-β/Smad, IGFBP-3 and MAPK pathways have been proposed as targets for 1α,25(OH)2D3 
upstream of the human p21 gene, as their inhibition has lead to abolishment of p21 induction 
(Verlinden et al., 1998; Boyle et al., 2001; Wu et al., 2007). Inductions of TGF-β and IGFBP-3 
are linked to each other and may provide extension in the p21 response time, as their inhibition 
blocked the p21 mRNA or protein response in 24 or 72 h, respectively. MAPK pathways 
represent a non-genomic target of 1α,25(OH)2D3 and seemed to abolish also p21 basal 
expression, so their role in 1α,25(OH)2D3 response remains obscure (Wu et al., 2007). 
Nevertheless, our results do not preclude the role of TGF-β or MAPK pathways in upregulation 
of p21 by 1α,25(OH)2D3, although we do have evidence of VDR presence on the regulatory 
regions of the p21 gene. The intracellular signaling pathways could contribute to or even be 
essential in the transcriptional response via phosphorylation of VDR or its co-factors. Therefore, 
our results are not in conflict with the indirect effects of 1α,25(OH)2D3 to p21 gene expression, 
but instead, the indirect effects can further boost the transcriptional response to the ligand, thus 
making the response more robust and less error-prone. 
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6.2 Regulation of the human p21 gene by p53 and its role in 1α ,25(OH)2D3 
response 
The adjacent location of the p53 and VDR binding sites on two regions suggests interplay 
between these two factors. The VDR gene is also a transcriptional target of p53 and its related 
proteins p63 and p73 (Welsh, 2007). However, no synergistic or even additional effect of 
1α,25(OH)2D3 and 5-FU on p21 expression was observed, and p21 is highly responsive to 
1α,25(OH)2D3 in the p53 negative MDA-MB453 cells (unpublished data, III and IV). One could 
assume that the chromatin remodeling by one of the factors would ease transcription initiation by 
the other, but the lack of even additional effects upon simultaneous activation suggests that the 
agitation of transcriptional machinery on the p21 gene TSS by liganded VDR-RXR heterodimers 
is hindered during high p53 induction. This could occur via co-factor squelching or steric 
interference. Nevertheless, the regions that contain multiple REs constitute hotspots on the p21 
promoter and show high regulatory potential on the whole-genome in silico prediction for 
functional elements based on conservation, predicted deoxyribonuclease hypersensitivity and 
transcription factor training sets (Taylor et al., 2006 and the linked data in the UCSC genome 
browser). 
In the skin the differential response to p53 and 1α,25(OH)2D3 translates to UV-response of 
different intensities: activation of p53 pathway alerts cells to significant levels of DNA damage 
and highly induces p21 to eliminate proliferation, while moderately increased 1α,25(OH)2D3 may 
only inform cells about (and possibly protects them from) UV exposure and the possibility of 
damage (Holick, 2003a) via moderately increasing p21 expression, which leads to slower 
progression of the cell cycle. During the alarm, the subtle message from 1α,25(OH)2D3 becomes 
unnecessary, but otherwise 1α,25(OH)2D3 constitutes a modest but stable signal for cells to 
restrict proliferation. 
 
6.3 Divergent CoA profiles associated with VDR and PPARβ /δ 
The basal transcriptional activity of PPARs resulting from the semi-orphan structure of the 
receptors and/or presence of endogenous ligands poses different settings for agonist induced 
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dynamics of co-factor recruitment when compared to VDR (Fyffe et al., 2006; Molnar et al., 
2005). The on/off model of co-factor exchange proposed for other NR1 group NRs has also been 
suggested for PPARs (Michalik et al., 2006). In vivo, PPARα readily associates with CoAs, such 
as p300, also in the absence of ligand, whereas ligand induces this interaction only by 40 % 
(Tudor et al., 2007). We saw an interaction between PPARβ/δ and MED1 on some PPREs of the 
PDK genes also in the absence of exogenously added ligand, although PPARγ has been shown to 
interact with the Mediator complex in a strictly ligand-dependent manner in vitro (Ge et al., 
2002). The PDK PPREs also exhibit p-Pol II association in the absence of MED1 association. 
Recently, the MED1 subunit of the Mediator complex was shown to be dispensable for PPARγ 
target gene transactivation and Mediator recruitment to target promoters in undifferentiated 
mouse embryonic fibroblasts (Ge et al., 2008). VDR lacks the constitutive activity displayed by 
PPARs (Molnar 2005), and MED1 protein association with VDR appears strictly ligand 
dependent. Surprisingly, the VDR shows association with other CoA, such as CBP, also in the 
absence ligand, either due to interactions with other transcription factors on these regions or 
uncharacterized basal association. The latter is supported by our quantitative data from MDA-
MB453 cells in (IV), where CBP association on ligand-responsive regions is significantly 
reduced upon 15 min of 1α,25(OH)2D3 treatment, whereas MED1 protein association is 
increased. In general, our data support differential association of co-factors, and especially 
MED1, of un-liganded VDR and PPARβ/δ, where the latter possesses ability to interact with 
CoAs also in the absence of ligand. 
 
6.4 Role of HDACs in regulation of CDKI genes and convergence with 
1α ,25(OH)2D3 response 
 The p21 gene has been suggested as one of the main targets of HDAC inhibitors in executing 
their anti-proliferative activity, but in mammary cell lines the INK4 family CDKI genes p18 and 
p19 displayed a pronounced response to TSA, whereas the p21 gene was only mildly induced, 
terms of fold change (III). The transcriptional response of the CDKI genes to TSA correlated 
neither with the basal association of specific HDACs nor with changes in histone acetylation on 
the TSS and proximal promoter. HDAC patterns and acetylation changes showed some 
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congruence, since HDAC3 was only enriched on TSSs that showed induced acetylation upon 
TSA treatment, but not on the p27 gene TSS. Nevertheless, the knockdown of HDAC3 mimics 
the effects of TSA resulting in high induction of p18 expression. Interestingly, the knockdown of 
HDAC3 attenuates the response to TSA, suggesting HDAC3 as one of the main targets of TSA. 
The effects of HDAC3 were not dependent on NCoR1, as inhibition of NCoR1 gene expression 
failed to produce similar effects on the steady state expression of the p18 gene and even further 
induced the response to TSA. These results rule out increased histone acetylation resulting from 
inhibition of NCoR1 dependent HDAC3 as the cause for high transcriptional induction of p18 by 
TSA or siRNA inhibition of HDAC3. The mechanism of HDAC inhibitor induced gene 
expression is yet far from well-characterized, as they produce a general increase in histone 
acetylation that is not transmitted to a broad transcriptional activation (Smith 2008). The 
transcription factor Sp1 is considered as a none-histone target for HDACs, and hence a putative 
provider of target gene selectivity in response to HDAC inhibitors (Huang 2005, Lee 2005). But 
as all studied CDKI genes contain GC-boxes and are regulated by Sp proteins irrespective of their 
responsiveness to HDAC inhibitors, a change in the transcriptional activity potential of Sp 
proteins would not alone provide an explanation for differential responses to TSA.  
Besides that of the p21 gene, transcript levels of other CDKI encoding genes were also up-
regulated by 1α,25(OH)2D3 in the mammary cell lines studied here, although in a less coherent 
manner (III). As previously reported with the p21 gene, a combination of an HDAC inhibitor and 
1α,25(OH)2D3 resulted in higher induction of CDKI gene expression than either substance given 
alone (Gaschott et al., 2001; Abedin et al., 2006). The additional or in some cases synergistic 
effect appears already at 2 h, and thus is unlikely a result of de novo protein synthesis. 
Modulating activity of VDR, NCoR1 and HDACs by siRNA interference results in a more 
restricted response: inhibition of either VDR or NCoR1 increases the 3 h TSA response of INK4 
genes in two cell lines and inhibition of either the HDAC3 or HDAC4 genes increases the 
transcriptional response of both p21 and CYP24A1 genes to 3 h of 1α,25(OH)2D3 treatment only 
in MCF-7 cells (III, Fig 4 and S4). These results suggest that un-liganded VDR and NCoR1 
attenuate the transcriptional response to TSA, while HDACs attenuate the response to 
1α,25(OH)2D3 and combined use of TSA and 1α,25(OH)2D3 can overcome these barriers. Very 
recently the anti-proliferative potential of 1α,25(OH)2D3 and TSA has been combined to one 
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molecule that simultaneously acts as a VDR agonist and an HDAC inhibitor (Tavera-Mendoza et 
al., 2008). 
 
6.5 1α ,25(OH)2D3 induces cyclical chromatin looping and transcription 
factor association on the regulatory regions of p21 
The cyclical transcription models provided by multiple studies pose a significant challenge for 
the examination of gene regulation by NRs, making it extremely difficult to generalize results 
from one time point to describe the whole response. Hence, we used ChIP, 3C and real-time PCR 
assays with a dense time course to understand how association of the transcription factor (VDR), 
co-factors and chromatin modifications on multiple REs and the TSS as well as the chromatin 
looping from REs to TSS leads to transcriptional response to the ligand. Based on our results we 
created a model presented in Figure 1 and discussed below. In this model, the response on 
chromatin was initiated by MED1 and LSD1, which showed associated strongly with the TSS 
and proximal 1α,25(OH)2D3-responsive region, although the binding of VDR only begun to rise 
at this point. Based on the general principle of NR function, that the ligand can only affect 
transcription through the receptor, the recruitment of LSD1 and MED1 must be dependent on 
VDR. Either a very low level of liganded VDR is sufficient to recruit these factors, or VDR peaks 
already before the 15 min time point for the first time to recruit the factors. Nevertheless, the 
peak in LSD1 binding on TSS at this early time point, when H3K4me2 is still rising, implies that 
its main substrate on the p21 promoter is H3K9me1/2, and that LSD1 is acting as a CoA rather 
than CoR, as its inhibition leads to lower basal expression of the p21 gene. This would also 
explain the subsequent H3K9ac peak that is enabled by removal of H3K9me1/2 by LSD1. 
Controversially, both basal and ligand-induced H3K9ac are significantly higher after LSD1 
knockdown, a phenomenon possibly linked to the repressive H3K4 demethylase activity of the 
enzyme.  
CBP is able to recognize H3K9ac through its bromodomain and acetylates H3K14, and 
accordingly, CBP peaks at 30 min on the TSS, after the increase in H3K9ac (Zeng et al., 2008). 
H3K9ac is also recognized by the TAF1 subunit of the basal transcriptional machinery, which 
enables initiation of transcription (Agalioti et al., 2002). The lack of effect upon inhibition of 
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CBP on transcriptional response of p21 to 1α,25(OH)2D3, though, suggests that it can be replaced 
by another HAT. The putative H3K14ac created by CBP is recognized by the bromodomain of 
BRG1 that is the catalytic subunit of PBAF chromatin remodeling complex. The abolishment of 
H3K4me2 and H3K9ac from the TSS following the peak in CBP and in the histone 
modifications, preceding initiation of transcription, suggests ligand-dependent histone eviction 
from the TSS. Histone eviction by 1α,25(OH)2D3-responsive transcription has also been reported 
previously for the RANKL gene, where eviction also occurred on an VDRE containing region 
(Ewing 2007). On regulation of the p21 gene, histone modification clearance only occurs at the 
TSS containing region, whereas H3K4me2 and especially H3K9ac are induced by the ligand, 
suggesting that effective receptor binding and looping do not require nucleosome eviction from 
VDREs. 
Besides modulation of binding surfaces of chromo- and bromodomain proteins, LSD1 has been 
indicated to be essential in a molecular mechanism of chromatin looping as mentioned in the 
literature part of this thesis (see section 2.1.5.2). In short, Perillo and colleagues proposed a 
model, where H3K9 demethylation by LSD1 causes localized oxidative damage on DNA, which 
is then repaired by base-excision repair complex that contains a topoisomerase that catalyzes the 
transport of one DNA double-helix through another, relaxing the tortional stress on the DNA 
strand and thereby enable chromatin looping by making the DNA strand more bendable (Perillo 
et al., 2008). In correlation with earlier data on steroid NRs, siRNA knockdown of LSD1 inhibits 
chromatin looping from distal 1α,25(OH)2D3-responsive regions to the TSS of the p21 gene. 
LSD1 knockdown also attenuates the transcriptional response to 1α,25(OH)2D3 resulting in 
similar level of the p21 transcript than does MED1 knockdown, and disturbs the changes in 
histone modifications. The causal relationship between all the effects of LSD1 gene knockdown is 
complex: the influence of 1α,25(OH)2D3 on the chromatin modifications on the TSS requires 
looping from distal VDREs, but on the other hand, a certain pattern of chromatin modifications or 
as proposed by Perillo and colleagues, certain side products from chromatin modifying enzymes 
may be required for looping. In contrast to results by Perillo and colleagues, though, we observed 
drastic ligand-dependent changes in LSD1 association especially on the TSS, whereas they 
reported that LSD1 is constantly bound to both TSS and the ERα enhancer and does not respond 
to ligand. Besides fitting to the cyclical model of NR-mediated gene regulation better than 
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constant presence of LSD1, the dynamic association of LSD1 on both REs and TSS provides 
stricter regulation of looping.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1: Model of activation of p21 transcription by 1α ,25(OH)2D3. Simplified model of transcription 
factor and co-factor association, histone modifications, chromatin looping and transcript production in 
transcriptional response of p21 to 1α,25(OH)2D3. Transparent ovals indicate low association. Direct 
associations between individual proteins on this figure are incidental.    
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Surprisingly, and unlike that of CBP, the siRNA knockdown of HDAC3 and especially HDAC4 
severely obscured the transcriptional response. Knockdown of HDAC4 induces basal expression 
of p21 to 2-fold, although the effects on basal H3K9ac levels are relatively mild. This suggests 
that HDAC4 deacetylates either other lysine residues or non-histone targets participating in 
transcriptional response. The binding pattern of HDAC4 is also more aberrant than that of 
HDAC3, as it rises relatively late and incoherently on distinct regions. Surprisingly, HDAC4 is 
essential for both induction of H3K9ac on 1α,25(OH)2D3-responsive regions of the p21 gene 
studied here, the abolishment of histone modifications from the TSS containing region as well as 
for optimal chromatin looping from the distal region to the TSS. As binding and substrate 
specificity as well as protein associations of HDAC4 are still largely unknown, the reason for its 
crucial importance in the 1α,25(OH)2D3 response of the p21 gene remains unresolved. 
The enrichment patterns of HDAC3, NCoR1 and YY1 on the TSS resemble those of H3K9ac and 
H3K4me2, with a drastic decrease at 45 to 60 min. On the contrary, on the 1α,25(OH)2D3-
responsive regions of p21 the association of the repressors decreases during the first 15 to 30 min 
and increases again at later phases, while the histone modifications show an opposite pattern. 
First of all, the similarity in binding patterns of NCoR1 and YY1, as well as the similarity in 
effect of their removal on 1α,25(OH)2D3-responsive steady state accumulation of p21 transcripts 
suggest that they work in concert to moderate p21 transcription. Secondly, these results imply 
that the CoRs repress mostly the responsive regions during the transcription cycles, whereas the 
low amount of histone modifications on the TSS containing regions does not provide substrates 
for the CoR associated HDACs. Interestingly, two of the responsive regions show low but 
significant basal looping to TSS and association of certain CoRs, which suggests that they 
actively connect to the TSS region in order to restrict transcription when 1α,25(OH)2D3 is not 
present. 
Our data shows periodicity in association of VDR, Pol II, and certain co-factors, as well as in 
looping and the accumulation of the steady state p21 gene transcripts, where events are repeated 
every 45 to 60 min without any other synchronization besides the ligand treatment. Metivier and 
colleagues presented similar duration but far more symmetrical transcription cycles on estrogen-
induced and α-amanitin synchronized cells, suggesting that it represents general timing of NR 
mediated transcription cycles through a universal mechanism (Metivier et al., 2003). Irrespective 
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whether the cyclical removal of transcriptional regulators occurs from protein degradation or 
chaperone-mediated disassembly, it provides means to stringently regulate the transcriptional 
response to endure only during the presence of the ligand and in the absence of contradictory 
messages from cellular signaling pathways. 
The in vitro based model of VDR-RXR-mediated transcription reviewed in the literature part of 
this thesis, describes the PBAF remodeling complex as essential for ligand-responsive 
transcription from chromatin template, whereas transcription from naked DNA is not responsive 
to ligand and requires only VDR-RXR, Pol II-TAFIID complex and the Mediator complex. This 
implies that the main function of the ligand is to promote chromatin remodeling, enabling VDR 
to activate Pol II on an open chromatin structure. In vivo, this is further complicated by 
requirement of chromatin looping from distal REs to the TSS to provide physical contact between 
VDR-RXR and the basal transcription machinery, respectively, via the Mediator complex. Based 
on our results, ligand-responsive dynamic association of VDR, co-factors and histone 
modifications, chromatin looping and transcript accumulation are highly interlinked, and 
disturbance of either the Mediator complex or distinct histone modifiers will alter all levels of 
regulation. Removal of either HDAC4, LSD1 or MED1 impairs the ligand-dependent clearance 
of histone modifications from the TSS as well as chromatin looping from distal REs, both of 
which are essential for the induction of p21 expression by 1α,25(OH)2D3. 
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7. Summary and conclusions 
The four scientific papers that constitute this thesis further establish p21 as a primary 
1α,25(OH)2D3 target gene and provide insight into the mechanism of NR-dependent activation of 
transcription. 
The novel 1α,25(OH)2D3-responsive regions contribute to transcription of p21 
By screening 7 kbp of the p21 promoter by ChIP assays, we characterized three regions with 5-
FU-induced p53 enrichment, one of which had not been previously characterized, and three novel 
regions with 1α,25(OH)2D3-induced VDR enrichment, two of which harvested also p53. The 
direct role of the characterized 1α,25(OH)2D3-responsive regions on regulation of p21 expression 
is illustrated by the their association with VDR-Pol II complexes as well as by their ligand-
dependent looping to the p21 TSS. We show coherent transcriptional response of the p21 gene to 
1α,25(OH)2D3 in three mammary cell lines with different stages of malignancy. 
CoA association of VDR 
Comparison of CoA association of VDR and PPARβ/δ on regulatory regions of p21 and genes of 
the PDK family, respectively, supports the stricter ligand-dependency of the former. The 
modulation of 1α,25(OH)2D3 response by CoRs and associated HDACs showed that combined 
application of 1α,25(OH)2D3 and the HDAC inhibitor TSA achieved maximal induction of p21 
and the other CDKI genes steady state mRNA levels, relative to the control treatment. Subsequent 
assays using gene selective siRNA knockdown revealed that this was due to the attenuation of 
1α,25(OH)2D3 response by HDAC3 and HDAC7 and attenuation of TSA response by the NCoR1 
and un-liganded VDR.  
Recurrent association of regulatory factors, chromatin looping and p21 transcript accumulation 
in response to 1α,25(OH)2D3 
By ChIP and 3C assays, we demonstrate a sequential association of VDR, p-Pol II and co-factors 
on regulatory regions of the p21 gene accompanied by dynamic chromatin looping. The response 
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of the p21 gene to 1α,25(OH)2D3 is initiated by induction of MED1 on both the TSS and the 
proximal ligand-responsive regions. Subsequently H3K9ac, H3K4me2 and the CBP become 
highly enriched on the TSS with simultaneous or slightly delayed association of VDR and Pol II 
on the 1α,25(OH)2D3-responsive regions. This is followed by an initial peak in mRNA 
accumulation. Prior to the second peak in p21 gene steady state mRNA levels, VDR, MED1, p-
Pol II and LSD1 are strongly enriched within the 1α,25(OH)2D3-responsive regions accompanied 
by a high level of chromatin looping to the TSS. Concurrently with transcriptional activation, 
binding of HDAC3, NCoR1 and YY1 to ligand-responsive regions decreases, but at later time 
points, these factors are region-specifically re-introduced. Inhibition of HDAC4, LSD1 or MED1 
disturbs both the ligand-induced changes in histone patterns and the chromatin looping, leading to 
attenuation and distortion of cyclical transcript accumulation. In conclusion, our results suggest 
strong interplay between histone modifications, chromatin looping and transcriptional response in 
gene regulation by NRs. 
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8. Future aspects 
The data presented in this thesis opens up some interesting questions. First of all, the study on the 
role of HDACs on CDKI regulation suggested that HDAC3 is the major target for TSA, but did 
not provide any explanation of the selectivity of TSA on CDKI induction. This could be studied 
by combined TSA treatment and knockdown of transcription factors that are known to regulate 
CDKI genes, such as the Sp proteins, to see which factors are essential for the effect. 
The individual histone modifications seem to play a crucial part in gene regulation, but the 
interactions between the modifications and the modifiers are not well characterized. To analyze 
the roles of distinct HDACs in specific histone modifications, their expression could be 
individually knocked down by siRNA followed by ChIP assay or Western blot with antibodies 
against distinctly modified histones. Also, the histone modification pattern preferred for binding 
by distinct HDACs could be studied by ex vivo co-immunoprecipitation or two-hybrid assays.  
The importance of the histone modifying enzymes on the regulation of the human p21 gene by 
1α,25(OH)2D3 and the reduction of the activity-linked modifications from the TSS containing 
region implies that they might serve as markers for bromo-, chromo- or PHD-containing 
chromatin modifiers. First of all, the putative nucleosome eviction could be studied by 
micrococcal nuclease sensitivity assays and/or ChIP using antibodies against pan-histone H3 and 
H4. Secondly, individual knockdown of the catalytic ATPase subunits of mammalian chromatin 
remodeling complexes by siRNA and the effect on ligand response provides a screening method 
to find the essential complexes. The timing of their association could be studied using ChIP, and 
the their role in establishment of chromatin modifications and looping by combined siRNA and 
ChIP or 3C.  
As the amount of information on gene regulation on chromatin level is exponentially increasing, 
the complete and all-explaining model of metazoan transcription seems un-attainable with close 
to infinite level of complexity. NRs were once thought to represent straightforward regulators of 
gene expression that could be turned on by introduction of lipophilic ligand and thus were 
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thought to provide a simple model system for the regulation of transcription. Recent data presents 
this regulation as anything but simple, where correctly timed and targeted NR mediated responses 
are provided by dynamic interactions within the chromatin context via co-factors and 
incorporation of messages from cellular signaling pathways to meet the needs of the cell and 
ultimately the whole organism. 
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